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“the only interesting thing about vertebrates is the neural crest“ 
 
P. Thorogood, 1989 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table of content 
 
I 
Table of content 
Abbreviations................................................................................................................................. III 
Summary............................................................................................................................................ 1 
Zusammenfassung .......................................................................................................................... 2 
1  Introduction............................................................................................................................... 4 
1.1  Pluripotent stem cells........................................................................................................................4 1.1.1  Human embryonic stem cells............................................................................................................... 5 1.1.2  Induced pluripotent stem cells ........................................................................................................... 6 
1.2  The neural crest...................................................................................................................................8 1.2.1  Neurulation and neural crest specification ................................................................................... 9 1.2.2  Fate of cranial neural crest cells .......................................................................................................11 1.2.3  Fate of trunk neural crest cells..........................................................................................................15 1.2.4  Environmental cues for in vitro neural crest cell differentiation.......................................17 1.2.5  Differentiation of neural rosettes and neural crest cells from pluripotent  stem cells .....................................................................................................................................................19 1.2.6  Therapeutic potential of pluripotent stem cell‐derived neural crest cells ....................20 
1.3  Aim of the project............................................................................................................................. 21 
2  Materials and Methods.........................................................................................................22 
2.1  Materials ............................................................................................................................................. 22 2.1.1  Cell lines ......................................................................................................................................................26 2.1.2  Cell culture media ...................................................................................................................................26 2.1.3  Coating materials ....................................................................................................................................28 2.1.4  Buffers, solutions and gels for immunological detection methods ...................................28 
2.2  Methods ............................................................................................................................................... 30 2.2.1  Cell culture and cell separation.........................................................................................................30 2.2.2  Electrophysiological recordings.......................................................................................................34 2.2.3  Time‐lapse imaging................................................................................................................................35 2.2.4  Immunocytochemical analysis..........................................................................................................35 2.2.5  Histological stains...................................................................................................................................37 2.2.6  Molecular analysis ..................................................................................................................................37 2.2.7  Immunoblot analysis .............................................................................................................................42 
 
  
 
 
Table of content 
 
II 
3  Results........................................................................................................................................45 
3.1  Formation of neural tube­like structures in plated embryoid bodies ........................... 45 
3.2  Human embryonic stem cell­derived neural tube­like structures display a dorsal­
ventral patterning............................................................................................................................ 46 
3.3  Neural crest cells accumulate in distinct aggregates in the periphery of plated 
embryoid bodies............................................................................................................................... 47 
3.4  Crescent­shaped aggregates form in the periphery of isolated neural tube­like 
structures............................................................................................................................................ 50 
3.5  Switching Cadherin expression patterns in human  embryonic stem cell­derived 
neural crest cells mimic in vivo Cadherin distribution ....................................................... 51 
3.6  Spontaneous differentiation of peripheral neurons in the periphery of plated 
embryoid bodies............................................................................................................................... 53 
3.7  Isolation of neural crest cells by manual picking.................................................................. 53 
3.8  Microarray analysis shows substantial gene expression differences between 
  neural crest cells and a human  embryonic stem cell­derived neural stem cell 
population .......................................................................................................................................... 58 
3.9  Isolated neural crest cells can readily be differentiated into different types of 
peripheral neurons ......................................................................................................................... 59 
3.10  Isolated neural crest cells give rise to putative Schwann cells...................................... 62 
3.11  Isolated neural crest cells give rise to mesenchymal  derivatives ............................... 64 
4  Discussion.................................................................................................................................67 
4.1  Neural crest development can be recapitulated in vitro .................................................... 67 
4.2  The human embryonic stem cell­based model as source for multipotent neural crest 
cells ....................................................................................................................................................... 72 
4.3  Outlook ................................................................................................................................................ 82 
5  References ................................................................................................................................84 
6  Acknowledgement .................................................................................................................98 
7  Appendix ...................................................................................................................................99 
8  Declaration............................................................................................................................ 100 
9  Curriculum Vitae ................................................................................................................. 101 
 
  
   
 
Abbreviations 
 
III 
Abbreviations 
AA ascorbic acid 
APS ammonium persulfate 
BDNF brain-derived neurotrophic factor 
BMP bone morphogenetic protein 
BRN3A brain-specific homeobox/POU domain protein 3A 
cDNA complementary deoxyribonucleic acid  
CNS central nervous system 
DAPI 4′,6-Diamidino-2-phenylindol 
dcAMP dibutyl cyclic adenosine monophosphate 
EMT epithelial-to-mesenchymal transition 
EBs embryoid bodies 
EGF epidermal growth factor 
ES embryonic stem  
FACS fluorescence activated cell sorting 
FCS fetal calf serum 
FGF fibroblast growth factor 
Fn fibronectin  
GDNF glial-derived-neutrophic factor 
GFAP glial fibrillary acidic protein 
HNK-1 human natural killer-1 
HRP horseradish peroxidase 
hES human embryonic stem 
ICM inner cell mass 
iPS induced pluripotent stem 
L liter 
Ln laminin 
lt-hESNSCs long term proliferated human embryonic stem cell-derived neural stem cells 
MEF murine embryonic fibroblasts 
mL milliliter  
NC neural crest  
p75NTR low affinity nerve growth factor receptor (p75NTR) 
NGS normal goat serum 
NRG-1 neuregulin-1 
PAX paired box  
  
   
 
Abbreviations 
 
IV 
PBS phosphate buffered saline 
PFA paraformaldehyde 
PNS peripheral nervous system 
PO  poly-L-ornithine 
RA retinoic acid 
RNA  ribonucleic acid 
rpm rounds per minute 
RT-PCR reverse transcriptase-polymerase chain reaction  
SDIA stromal-derived-inducing-activity 
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis 
SHH sonic hedgehog 
SMA smooth muscle actin 
SOX SRY-related HMG-box 
SSEA stage-specific embryonic antigen 
TGF transforming growth factor 
TH tyrosine hydroxylase 
TFAP2A transcription factor activating enhancer binding protein 2 alpha 
TRA tumour recognition antigens 
Wnt wingless/Int 
 
  
 
 
Summary 
 
1 
 
Summary 
The neural crest is a transient embryonic cell population with outstanding characteristics. Af-
ter their delamination from the closing neural tube, neural crest cells migrate extensively 
throughout the body and differentiate into highly diverse cell types, including peripheral neu-
rons and glia, but also mesenchymal tissues of the head region. Neural crest development has 
been extensively studied in several animal models, however, the neural crest of primates, par-
ticularly of humans, remains largely inaccessible. The research on human embryonic stem 
(hES) cells offers a highly interesting possibility to study events of early embryonic develop-
ment in an in vitro setting. In the thesis presented here, differentiating hES cells were used to 
study human neural crest development. Remarkably, the process of neural crest delamination 
is mimicked in the cell culture dish, thereby recapitulating early developmental processes. 
Cultivation of spontaneously differentiated embryoid bodies (EBs) in neural differentiation 
medium yielded prominent neural rosettes that, according to their morphology and marker 
expression, resembled a primitive form of the neural tube. Neural crest cells, identified by 
expression of the neural crest-associated markers p75NTR, HNK-1, SOXE, and AP2α, mi-
grated from those neural tube-like structures over the fibroncetin-coated dish and formed dis-
tinct crescent-shaped aggregates at a defined distance. This process is accompanied by a char-
acteristic cadherin switch, which is typical for an epithelial-to-mesenchymal transition, as it 
occurs in neural crest development in vivo. The aggregation of neural crest cells into clearly 
distinguishable clusters could be exploited to purify them from the heterogenous cell culture 
by manual picking. The level of purity, assessed by expression of p75NTR and SOXE, of the 
obtained cell population resembled cell populations isolated by Fluorescence Activated Cell 
Sorting for p75NTR (>95%). Comparison with a neural stem cell population obtained from 
the same parental hES cell line via microarray analysis confirmed upregulation of neural crest 
cell markers and distinct differences towards neural stem cells. The purified neural crest cell 
population could be differentiated into peripheral neurons and glia, as well as to smooth mus-
cle cells, adipocytes, osteoblasts and chondrocytes.  
The hES cell-based culture model presented here provides access to early human neural crest 
development and offers multiple possibilities to study the delamination, migration and differ-
entiation of neural crest cells. Moreover, this model system provides potential for modeling of 
neural crest-associated diseases and pharmacology testing.  
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Zusammenfassung 
Bei der Neuralleiste handelt es sich um eine transiente, embryonale Zellpopulation mit außer-
gewöhnlichen Eigenschaften. Nach Verlassen des sich schließenden Neuralrohres migrieren 
die Neuralleistenzellen durch den Körper und differenzieren in verschiedenste Zelltypen. Zu 
ihren Nachkommen gehören periphere Neurone und Gliazellen, aber auch mesenchymales 
Gewebe aus der Kopfregion. Die Entwicklung der Neuralleiste wurde in verschiedenen Tier-
modellen intensiv erforscht. Auf Grund ihrer Unzugänglichkeit ist  über die Neuralleiste in 
Primaten, speziell im Menschen, jedoch nur wenig bekannt. Die Verwendung von humanen 
embryonalen Stammzellen bietet eine sehr interessante Möglichkeit die Vorgänge der frühen 
Embryonalentwicklung in vitro nachzuvollziehen. In dieser Arbeit wurden differenzierende 
humane embryonale Stammzellen verwendet, um die Entwicklung der Neuralleiste zu unter-
suchen. Tatsächlich konnte gezeigt werden, dass typische Vorgänge der Neuralleistenent-
wicklung in der Zellkulturschale abgebildet werden. Durch Kultivierung von spontan 
differenzierten Embryoid Körperchen in Medium, welches die neurale Differenzierung be-
günstigt, wurden neurale Rosettenstrukturen gewonnen, die in ihrer Morphologie und Mar-
kerexpression einer primitiven Form des Neuralrohres ähneln. Neuralleistenzellen, welche 
durch die Expression der Neuralleistenmarkern p75NTR, HNK-1, SOXE, and AP2α identi-
fiziert wurden, migrierten von den Neuralrohr-ähnlichen Strukturen über die Fibronektin-
beschichtete Schale, um schließlich in einem definierten Abstand halbmondförmige Aggrega-
te zu bilden. Dieser Prozess wurde von einem charakteristischen Cadherin-Switch begleitet, 
welcher typisch für eine epithelial-mesenchymale Transition ist, die in der Neuralleistenent-
wicklung in vivo ebenfalls zu beobachten ist. Die Aggregation von Neuralleistenzellen zu klar 
abgegrenzten Clustern konnte dazu genutzt werden, sie durch manuelle Isolation aus der hete-
rogenen Zellkultur aufzureinigen. Die auf diese Weise angereicherte homogene Zellpopulati-
on exprimierte die Neuralleistenmarker p75NTR und SOXE auf vergleichbar hohem Niveau 
wie die  Zellpopulationen, die durch Fluoresecence Acticated Cell Sorting auf p75NTR aufge-
reinigt wurden (>95%).  
Eine Genexpressionsanalyse zeigte im Vergleich zu einer neuralen Stammzellpopulation, 
welche aus der selben humanen embryonalen Stammzelllinie gewonnen wurde, eine deutliche 
Hochregulierung von wichtigen Neuralleisten-assoziierten Genen, sowie klare Unterschiede 
zu neuralen Stammzellen. Die gewonnene Population von Neuralleistenzellen konnte erfolg-
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reich in periphere Glia und Neurone sowie in die mesenchymalen Zelltypen Chondrozyten, 
Adipozyten, Osteoblasten und glatte Muskelzellen differenziert werden.  
Das hier vorgestellte Zellkulturmodell ermöglicht Zugang zur frühen Entwicklung der huma-
nen Neuralleiste und bietet dadurch zahlreiche Möglichkeiten um ihre Delamination, Migrati-
on und Differenzierung zu untersuchen. Dies eröffnet zudem das Potential, Neuralleisten-
assozierte Krankheiten zu modellieren und pharmakologische Wirkstoffe zu testen. 
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1 Introduction 
1.1 Pluripotent stem cells 
Stem cells are defined as undifferentiated cells that self-renew and possess the ability to dif-
ferentiate into progenitor cells that develop along specific pathways into mature cell fates. 
There are several types of stem cells, which differ in their origin and also in their differentia-
tion potential. Adult stem cells persist in several tissues of the adult body, e.g. blood, skin, 
teeth and bone marrow. They have the function to repopulate or repair their resident tissue in 
response to injury. Some of them possess a powerful, far-ranging differentiation potential 
(Clarke et al., 2000; Krause et al., 2001). However, as they do not give rise to all cell type of 
the three germ layers, they are termed multipotent. Pluripotent stem cells on the other hand 
are cells that possess the ability to differentiate into any somatic cell type. Today, basically 
three types of pluripotent cells are known; embryonic stem (ES) cells, which are found in the 
inner cell mass (ICM) of the early blastocyst, induced pluripotent stem (iPS) cells, which are 
artificially generated by reprogramming somatic cells into an ES cell-like state via the intro-
duction of reprogramming factors, and embryonic germ (EG) cells, which are derived from 
the testis. In the first part of the introduction human ES (hES) cells and iPS cells, as well as 
their therapeutic potential are discussed in detail (schematic overview in Fig.1). 
 
Figure 1: Schematic overview 
of the derivation of pluripotent 
stem cells. hES cells are derived 
from the inner cell mass of the 
blastocyst (upper lefthand side), 
while iPS cells are obtained by 
cellular reprogramming of somatic 
cells through the introduction of 
pluripotency factors (upper 
righthand side). Those pluripotent 
cells are able to give rise to tissues 
of all three germlayers (lower cen-
tral part). 
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1.1.1 Human embryonic stem cells 
In the early 80s, the first ES cells were isolated from the ICM of the mouse blastocyst and 
their unique properties of self-renewal and pluripotency were revealed (Evans and Kaufman, 
1981; Martin, 1981). Research on mouse ES cells provided valuable knowledge about main-
tenance and differentiation of pluripotent cells. In 1998, Thomson et al. succeeded in the deri-
vation of ES cells from the ICM of an 8-day-old human blastocyst. Just like their murine 
counterparts, hES cells exhibit pluripotency and self-renewal (Amit et al., 2000; Reubinoff et 
al., 2000; Thomson et al., 1998). They require different culture conditions compared to mouse 
ES cells though, as they cannot be cultivated under feeder-free conditions in the presence of 
leukemia inhibitor factor. Attempts have been made to cultivate hES cells on Matrigel, a 
growth factor containing substrate, with fibroblast-conditioned medium (Xu et al., 2001) or to 
supplement culture medium with fibroblast growth factor (FGF) and tumor growth factor-β 
(TGF-β; Amit et al., 2004). Importantly, in a clinical context, cells must not be cultivated with 
any source of animal-derived cells or substances. While in the beginning of hES cell research 
it was essential to co-cultivate hES cell lines with murine fibroblasts, more and more cell lines 
were established that have been cultured on human fibroblasts and therefore did not come into 
contact with animal substances of any kind during their generation (Inzunza et al., 2005). hES 
cells are identified by their typical marker expression of surface molecules such as stage-
specific embryonic antigen-3 (SSEA-3) and SSEA-4, as well as tumour recognition antigens 
1-60 (TRA1-60) and TRA1-80. Furthermore several transcription factors are associated with 
pluripotency, namely NANOG (Chambers et al., 2003; Mitsui et al., 2003), POU5F1, which is 
known as OCT4 (Nichols et al., 1998), and SOX2 (Avilion et al., 2003). 
Obviously, the generation and culture of hES cells raises ethical concerns, as it implies the 
destruction of human embryos during blastocyst stage. For the preparation of hES cells, em-
bryos that are surplus during in vitro fertilizations are used. Regulations differ according to 
the laws of the particular countries. In Germany, the key date regulation applies; meaning that 
research on hES cells is allowed if the cells have been generated before January 2005. How-
ever, the generation of hES cells is prohibited in Germany, so that hES cells have to be im-
ported from other countries. The research on hES cells is supported as their unique features 
promise large benefit for mankind. Due to their enormous differentiation potential, hES cells 
might have a promising potential in cell replacement therapies. hES cells have been success-
fully differentiated into cells from heart (Kehat et al., 2001), liver (Lavon et al., 2004), the 
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blood (Kaufman et al., 2001) and nervous system (Reubinoff et al., 2001; Zhang et al., 2001). 
However, medical application faces some major obstacles. For transplantation purposes it is 
essential that the cell population to be transplanted is free of unwanted mature cell fates that 
have developed analogue to the cell type of interest. Furthermore the population has to be free 
of undifferentiated pluripotent cells to exclude tumor formation. Therefore, highly selective 
differentiation and isolation paradigms have to be used. In addition to the problem of tumor 
formation of transplanted undifferentiated stem cells, therapeutical applications of stem cells 
harbor the problem of immune rejection in the case of allogenic transplants.  
Besides the potential of hES cells for advances in regenerative medicine, basic hES cell re-
search enables the detailed investigation of human development. On the one hand, basic hES 
cell research forces the investigation of the factors that keep stem cells in their undifferenti-
ated state. Recently, this knowledge led to the successful reprogramming of somatic cells to 
induced pluripotent stem (iPS) cells by introducing defined factors (Takahashi et al., 2007; 
Takahashi and Yamanaka, 2006; Yu et al., 2007). In addition, hES cells facilitate the study on 
differentiation processes leading to the formation of distinct mature cell types. Another utili-
zation of hES cells and hES cell-derived somatic cells in medical research is the development 
of new drugs for therapeutic application as well as toxicity testing. 
 
1.1.2 Induced pluripotent stem cells 
IPS cells are derived from somatic cells, which are reprogrammed to an undifferentiated ES 
cell-like state. They are referred to as ES cell-like because they do not only exhibit a similar 
morphology, but are also pluripotent, as they have been shown to give rise to cells of all three 
germ layers. The first murine iPS cells were generated 2006 by Takahashi & Yamanaka, hu-
man iPS cells were generated shortly after (Takahashi et al., 2007; Takahashi and Yamanaka, 
2006; Yu et al., 2007). In the first groundbreaking publications by Takahashi and colleagues, 
the four genes OCT4, KLF4, C-MYC, and SOX2, known to maintain pluripotency in ES 
cells, were introduced into embryonic fibroblasts by a viral approach, resulting in the genera-
tion of iPS cells that are able to generate cells of the three germ layers. The breakthrough in 
iPS cell research aroused enormous hope for medical applications. iPS cells may harbor the 
potential of autologues cell replacement therapies, which would overcome the problem of 
immune rejection. Another major application of iPS cell research is disease modeling by us-
ing patient-specific iPS cells. Since the seminal work by Takahashi and Yamanaka research-
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ers are constantly modifying and improving the technique of cellular reprogramming. For the 
medical progress of iPS cell research, it is indispensable to discover other somatic cells as 
starting material for reprogramming, which are easy to access from patients by a tissue bi-
opsy. In addition to embryonic foreskin fibroblasts, cord blood stem cells (Haase et al., 2009), 
adult skin fibroblasts (Park et al., 2008), keratinocytes (Aasen et al., 2008) and adipose stem 
cells (Sun et al., 2009) have been successfully used for reprogramming. Another approach to 
promote iPS cell research is to circumvent safety issues evoked by reprogramming. Using a 
retroviral or lentiviral vector for factor delivery genetically modifies the emerging iPS cells, 
as viral transduction leads to insertional mutagenesis of the host genome. Additionally, KLF4 
and C-MYC are potent oncogenes, which could eventually lead to cancer if an iPS cell-
derived transplant would be used in the clinic. Therefore studies aimed at alternative ap-
proaches, for example C-MYC and KLF4 were substituted with NANOG and LIN28 (Yu et 
al., 2007). Reprogramming was also achieved without C-MYC (Wernig et al., 2008) and even 
the introduction of only OCT4 was sufficient to reprogram neural stem cells (Kim et al., 
2009). However, a recent publication shows that reduction of reprogramming factors leads to 
reduction of reprogramming efficiency and differentiation potential (Lohle et al., 2011). In 
2010, Vierbuchen and colleagues showed that embryonic and postnatal fibroblasts could be 
directly converted into neurons by introducing three neural-lineage-specific transcription fac-
tors. Thereby a population of functional neurons was obtained without the intermediate step 
of tumorigenic pluripotent stem cells (Vierbuchen et al., 2010). For the diminishment of 
safety hazards, other delivery methods were explored, e.g. adenoviral vectors or even non-
viral approaches like recombinant proteins or non-viral plasmid transfection as well as 
episomal vectors. Recently somatic cell reprogramming was successfully achieved by admin-
istration of synthetic modified mRNA (Warren et al., 2010). Interestingly mouse and human 
cells could also be efficiently reprogrammed to pluripotency by transfection of microRNA 
only (Anokye-Danso et al., 2011; Miyoshi et al., 2011). The potential of iPS cells in terms of 
disease modelling and drug testing became strikingly clear when the first patient specific iPS 
cells were generated from patients suffering from genetic diseases like muscular dystrophies, 
spinal muscular atrophy (Ebert et al., 2009), amyotrophic lateral sclerosis (Dimos et al., 
2008), Parkinson’s disease (Soldner et al., 2009), Huntington's disease (Park et al., 2008), and 
Machado-Joseph disease (Koch et al., 2011). For review on recent advances in modelling neu-
rological diseases, see Ming et al., 2011. 
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1.2 The neural crest 
The neural crest is made up of a transient, highly migratory cell population found in all verte-
brate embryos. Neural crest cells give rise to a wealth of derivatives found in virtually all tis-
sues of the body and are therefore often considered as the “fourth germ layer”. Neural crest 
cells originate at the interface of the dorsal part of the closing neural tube and the adjacent 
epidermis. After their emergence, they start to migrate along defined pathways. The differen-
tiation potential of migrating neural crest cells is highly diverse. The cell fate of neural crest 
cells depends on the very region from which they emerge and on the migration pathway they 
choose. According to their axial level, they can be roughly subdivided into cranial, trunk, va-
gal (from the neck region) and sacral (from the tail region) neural crest cells. Cranial neural 
crest cells migrate into the pharyngeal arches and build up the facial cartilage and bone, neu-
rons and glia of the cranial ganglia, as well as melanocytes. A subpopulation of cranial neural 
crest cells is made up of cardiac neural crest cells, which differentiate into smooth muscle of 
the cardiovascular system, pericytes, and cardiac sympathetic and parasympathetic neurons.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Fates of the neural 
crest. Neural crest derivatives are 
shown exemplary in the chick em-
bryo at 7 somite stage (left side) 
and and 28 somite stage (right 
side). Pigment cells and sensory 
ganglia are derived from virtually 
every region. Mesoectoderm is 
exclusively derived from cranial NC 
cells, sympathetic ganglia exclu-
sively from trunk NC cells. The 
vagal and sacral NC cells give rise 
to enteric ganglia, vagal NC cells 
also to endocrine cells. A subset of 
trunk NC cells also gives rise to 
endocrine cells. (Adapted from Le 
Douarin et al., 2004). 
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Trunk neural crest cells differentiate into neurons and glia of the peripheral nervous system, 
melanocytes, as well as the medullary part of the adrenal gland (Le Douarin and Kalcheim, 
1999). Vagal and sacral neural crest cells populate the gut forming the enteric neurons and 
glia (Burns and Douarin, 1998) as well as endocrine cells (Fig. 2).  
 
1.2.1 Neurulation and neural crest specification 
The hour of birth of the central and peripheral nervous system (CNS; PNS) is the neurulation, 
as the neural plate lifts to form the neural tube. Neurulation and the induction of neural crest 
cells are provoked by the concerted action of bone morphogenetic proteins (BMPs), members 
of the Wnt family, fibroblast growth factors (FGFs), Notch and retinoic acid (RA). BMP, a 
member of the TGF-β protein family, is expressed in the non-neural epithelium. In the lifting 
neural plate BMP is repressed by the BMP antagonist sonic hedgehog (SHH), which is segre-
gated by the underlying notochord. As the neural tube is built by fusion of the neural folds, 
the neural plate border forms the dorsal organization of the neural tube, the roof plate of the 
later spinal cord, which expresses BMP. At the same time the ventral part of the neural tube, 
the developing floor plate, is ventralized by SHH expressed by the notochord. Thereby a gra-
dient of dorsal-ventral agents is established, at which neural crest cells will emerge from the 
BMP-rich dorsal part of the neural tube (Fig. 3). In addition to the dorsal-ventral gradient, the 
patterning of the anterior-posterior axis is crucial for neural crest induction. Candidates for 
this purpose are the posteriorizing signaling agents Wnt, FGF and RA, which are expressed in 
the non-neural ectoderm and the dorsal neural tube during neural crest emergence (Dickinson 
et al., 1995). Knock-out studies in mice depleting Wnt1 and Wnt3A resulted in neural crest 
defects, demonstrating the key role of these signaling molecules in neural crest induction 
(Ikeya et al., 1997). Experiments with Xenopus have shown that a dominant negative form of 
the FGF receptor 1 suppresses the neural crest inducing activity of the paraxial mesoderm 
(Monsoro-Burq et al., 2003), and temporally-regulated RA depletion resulted in specific neu-
ral crest abnormalities (Dickman et al., 1997). In addition, Notch signaling has an impact on 
neural crest induction. It has been shown that overexpression, as well as downregulation of 
Notch resulted in reduction of neural crest cells (Coffman et al., 1993; Endo et al., 2002). This 
effect is either mediated by Notch signaling controlling the inducing activity of BMP during 
neural crest development or by the fact that Notch signaling represses neurogenesis. Notch 
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therefore can also be regarded as a rheostat governing neural crest induction just like Sox2 or 
Nanog act as rheostats regulating stemness properties in ES cells (Rizzino, 2008). 
 
 
The complex gene network regulating the specification of first neural plate border cells and 
later neural crest cells has been widely studied in chicken, mice, lamprey, xenopus, and ze-
brafish by using knock-out animals or morpholinos and has shown some epistatic relation-
ships. Msx1/2, as well as Pax3/7, have been identified as important neural plate border speci-
fiers induced by dorsal BMP expression. They are expressed in the neural folds, and 
subsequently, as the neural folds fuse, in the dorsal part of the neural tube. Cells that are al-
ready specified as neural crest cells show additionally expression of the transcription factors 
Snai1, Snai2, Foxd3, Sox9, cMyc, AP2, and members of the Id family. As neural crest cells 
Figure 3: Neurulation and emer-
gence of neural crest cells. BMP is 
expressed in the non-neural ectoderm, 
but is repressed in the folding neural 
plate (1+2). As the neural folds fuse to 
form the neural tube, and the neural 
tube separates, it gets organized into 
the dorsal part (3+4; shown in purple), 
expressing BMP, and the ventral part 
(shown in green) expressing SHH. 
Thereby a descending BMP gradient is 
established (indicated in 3, right half). 
NC cells emerge from the dorsal part 
of the neural tube (3+4; shown in yel-
low). (Adapted from Liu and Niswan-
der, 2005). 
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leave the neural tube and start their migration, throughout the body they express the low affin-
ity nerve growth factor receptor p75NTR and the carbohydrate epitope HNK-1 on their sur-
faces, as well as the transcription factor Sox10 (Sauka-Spengler and Bronner-Fraser, 2008). 
The changes in the gene expression lead to a series of drastic cellular changes that evoke an 
epithelial-to-mesenchymal transition (EMT) of neural crest cells. Thereby neural crest cells 
change their epithelial characteristics to gain a migrating, mesenchymal phenotype (Duband 
et al., 1995). Switching cadherin expressions mediate one important cellular change during 
EMT. In the neural plate, the columnar epithelia cells express E-cadherin (Thiery et al., 1984). 
During neural tube closure E-cadherin expression is replaced by N-cadherin and NCAM, 
causing the neural folds to recognize each other and to fuse. As neural crest cells undergo 
EMT, they downregulate these cell adhesion molecules of strongly contacted cells and up-
regulate the type II Cadherins -6b, -7 and -11, which allow them to detach from the neuroepi-
thelium, gain their mesenchymal morphology and start their migration (Hatta et al., 1987; 
Nakagawa and Takeichi, 1995; Nakagawa and Takeichi, 1998). Another cellular event is the 
switch from tight junctions, e.g. Occludin and Claudins, to gap junctions, like Connexin43 
(Ikenouchi et al., 2003; Lo et al., 1997). As neural crest cells are guided by external cues on 
their migration pathways, upregulation of receptors for guidance molecules, like ephrin recep-
tors (Krull et al., 1997), Slit/Robo (Jia et al., 2005) and Neuropilin-l (Gammill et al., 2006; 
McLennan and Kulesa, 2007) is necessary. The junctions between neural crest cells and ex-
tracellular matrix are increased by an upregulation of integrins (Lallier and Bronner-Fraser, 
1993). At the time when neural crest cell migration ceases, cellular changes occur in a reverse 
manner to the onset of migration, e.g. N-cadherin is upregulated and expression of integrins 
decreases (Akitaya and Bronner-Fraser, 1992; Kasemeier-Kulesa et al., 2006).  
 
1.2.2 Fate of cranial neural crest cells 
In former times it was thought that all mesenchymal tissues, in the trunk as well as in the head 
are derived from the mesoderm. So it was a revolutionary time, as at the turn of the 19th cen-
tury the first scientists discovered an alternative origin of the mesenchymal tissues in the 
head, namely the neural crest. Many decades they were disbelieved due to the deadlocked 
opinion of the community and real attention was not paid until cell-labeling techniques were 
established, first in the avian (Johnston, 1966; Le Lievre and Le Douarin, 1975) and later in 
the mouse (Osumi-Yamashita et al., 1994).    
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The fate of cranial neural crest cells is determined by their spatial identity and the onset of 
migration. While early-migrating cranial neural crest cells form the mesenchymal derivatives, 
late-migrating neural crest cells predominantly stay close to the neural tube and form the cra-
nial ganglia (Kulesa et al., 2010). Neural crest cells from the diencephalon, the posterior part 
of the forebrain, in concert with the mesoderm, give rise to the frontal and parietal bones 
(Jiang et al., 2002). Neural crest cells arising from the mesencephalon and the rhombomeres 
populate the different pharyngeal arches, i.e. the anlage for the mesodermal tissues of the head 
(Fig. 4). 
 
Figure 4: Contribution of cranial neural crest cells to the facial skeleton. On the left side the 
migration pathways of cranial neural crest cells in the embryo are depicted. The color code gives evi-
dence about the origin of the facial bones of the adult skull shown on the right. Neural crest cells from 
the diencephalon and the anterior mesencephalon migrate between the eyes, to form the frontonasal 
plate (orange). Neural crest cells from the mesencephalon migrate to the first pharyngeal arch, where 
they will form the jaw (purple). From the rhombomeres (R) Neural crest cells migrate in three major 
streams, cells from R1+R2 migrate to the first pharyngeal arch (blue), cells from R4 to the second 
pharyngeal arch (yellow) and cells from R6 to the third pharyngeal arch (green). Neural crest cells 
from R3 and 5 migrate rostrally or caudally to join the main streams. Abbreviations: AS, alisphenoid 
bone; BA: Branchial arch (another term for pharyngeal arch commonly used in fish and amphibian); 
DE, dentary bone; di, diencephalon; FNP, frontonasal process; FR, frontal bone; HY: hyoid bone; IN, 
incus; MA, malleus; mes: mesencephalon; MX, maxillary bone; NA, nasal bone; PA: parietal bone; R: 
rhombomere; SQ, squamosal bone; ST, stapes; ZY, zygomatic bone. (From Santagati and Rijli, 2003). 
 
Neural crest cells from the mesencephalon and first and second rhombomere migrate between 
the eyes to form the palatal shelves and the upper jaw, and also populate the first pharyngeal 
arch, also called mandibular arch, which will give rise to the lower jaw and the neurons of the 
trigeminal ganglion. Cranial neural crest cells from rhombomere 4 populate the second arch, 
also called hyoid arch, which gives rise to the hyoid skeleton and the neurons of the facial 
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nerve. Cells migrating from rhombomere 6 and 7 will populate the posterior arches, giving 
rise to skeletal elements like thymus, thyroid and epiglottic cartilage (Lumsden et al., 1991; 
Schilling and Kimmel, 1994). The neural crest cells from rhombomeres 3 and 5 deviate ros-
trally or caudally to join the migrating streams of the even numbered rhombomeres (Sechrist 
et al., 1993). Besides the mesenchymal components, each pharyngeal arch also contains a 
cranial nerve, whose sensory part is build up by the respective neural crest cells. The first arch 
gives rise to the sensory part of the trigeminal nerve (V), the second to the facial nerve (VII), 
and the third to the glossopharyngeal nerve (IX).  
The more caudal cranial neural crest cells (from rhombomere 7 to somite 3) contribute to the 
mesenchym-derived heart and are therefore termed cardiac neural crest cells. They are in-
volved in the complex development of the aorticopulmonary septum and the conotruncal 
cushions and form the smooth muscle linings of the blood vessels (Kirby et al., 1983).  
Hindbrain segmentation, establishment, and maintenance are accompanied by expression of 
members from different gene families, of which the HOX gene code has been identified as a 
key player. In vertebrates, four HOX gene clusters are found, named a-d, and associated 13 
paralogue groups. The HOX code of the neural tube can only be partly transferred to the neu-
ral crest cells migrating from it. HOX2A is the most anteriorly expressed HOX gene, in the 
neural tube it is expressed caudally at the boundary of rhombomere 1 and 2. However, neural 
crest cells migrating from those rhombomeres, forming the first pharyngeal arch, do not ex-
press any HOX genes (Fig. 5).  
 
Figure 5: Migration pathways of NC cells to 
the pharyngeal arches and associated HOX 
gene expression. Schematic demonstration 
based on experiments in chick and mouse em-
bryos. The first pharyngeal arch is devoid of HOX 
expression (red), while the more caudal arches 
express the first four paralogues in ascending 
order. Abbreviations: BA, branchial (pharyngeal) 
arch; FB, forebrain; HB, hindbrain; MB, midbrain; 
Md, mandibular part of BA1; Mx, maxillar part of 
BA1; OV, otic vesicle r, rhombomere. (Adapted 
from Guthrie, 2007). 
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HOX2A expression is restricted to neural crest cells migrating to the second pharyngeal arch, 
namely from rhombomere 4 and the caudally and rostrally migrating neural crest cells from 
rhombomere 3 and 5. It has been shown that HOX gene expression is directly linked with 
skeletogenic potential. While the HOX negative neural crest cells of the first pharyngeal arch 
give rise to the most skeletal elements of the head, the neural crest cells expressing only 
HOX2A and HOX2B in the second pharyngeal arch give rise to only the middle ear and the 
lesser horn of the hyoid bone. The neural crest cells of the third and fourth pharyngeal arch, 
expressing additionally HOX3 and 4 genes, give rise to the greater horn of the hyoid bone, 
thymus, parathyroid and thyroid glands. In the trunk, where the neural crest cells express a 
higher number of HOX genes, no skeletal elements are formed (Trainor, 2003). 
For the guidance of neural crest migration, several models exist but yet the underlying 
mechanisms remain to be clarified. Those include population pressure and contact inhibition 
of movement, cell nudging, polarized cell movement and cell chemotaxis. Population pressure 
and contact inhibition of locomotion means cells migrate away from densely populated areas 
where new cells are born constantly, as it has been described for Xenopus neural crest cells 
(Carmona-Fontaine et al., 2008).  The term cell nudging has been established to describe that 
the contact with neighboring cells leads to a forward movement, induced by membrane bleb-
bing on the opposite side of the cell-to-cell contact. Cell nudging has been first described in 
1976 (Tickle and Trinkaus, 1976), the work of Jesuthasan suggests a similar phenomenon for 
zebrafish trunk neural crest cells, as the cells adhere to each other and even show a thickening 
of pertrusion after contact. The same work also shows that contact to the somites results in 
thinning of pertrusion and a rapid stop of motility (Jesuthasan, 1996). Another work on ze-
brafish neural crest cells showed that cells adapt a polarized morphology after their emer-
gence from the neural tube and start directed migration. This observed polarized cell move-
ment is contradictory to another publication where it has been shown that neural crest cells 
can reverse direction (Kulesa et al., 2000; Kulesa et al., 2005). Besides the cellular forces ac-
companying cell-to-cell contacts and morphology, cell chemotaxis has been demonstrated as 
powerful neural crest guide. Neural crest cells react on excitatory and inhibitory signals from 
their environment. Here differences exist between cranial and trunk neural crest cells, as cra-
nial neural crest cells migrate into the pharyngeal arches and trunk neural crest cells migrate 
along the somite region. In the head, signaling is needed that mediates the boundaries of the 
different streams. The crest-free spaces at R3 and R5 are mediated by the expression of 
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chemorepellents in the mesenchyme. Neural crest cells express Eph receptors and ephrin 
ligands that act with Eph/ephrins in the mesenchyme in a repulsive manner. Here also sema-
phorin-3A and -3F are expressed, which repel neural crest cells due to their expression of neu-
ropilin-1 and -2 receptor. Mutations of ErbB4, a neuregulin receptor expressed in R3 and R5, 
also results in abnormal neural crest cell invasions. Neural crest cells are attracted into the 
arches via C-X-C chemokine receptor type 4 (CXCR4) signaling. While the receptor CXCR4 
is expressed in migrating neural crest cells, its ligand, the stromal cell derived factor (SDF-1), 
is expressed on the migratory path of neural crest cells and in the pharyngeal arch region 
(Olesnicky Killian et al., 2009). The neuropilin-1 receptor not only has a function in the repel-
lence of neural crest cells from the mesoderm, but in their attraction and homing as well, as its 
ligand, the vascular endothelial growth factor (VEGF) expressed in the ectoderm of the pha-
ryngeal arch, has shown to have a strong attracting effect on neural crest cells (McLennan et 
al., 2010).  
 
1.2.3 Fate of trunk neural crest cells 
Trunk neural crest cells migrate in two major waves. The first neural crest cells that leave the 
neural tube migrate medio-ventral between the somites and the neural tube to either form the 
dorsal root ganglia close to the neural tube, or continue their migration ventrally to populate 
the sympathetic ganglia and adrenal chromaffin cells. The neural crest cells of the second 
wave migrate dorso-lateral between ectoderm and somites. These neural crest cells will con-
tribute to the melanocyte lineage (Fig. 6A). Vagal neural crest cells, which migrate from the 
neural tube close to the somites 1-7, and sacral neural crest, which migrate caudal to the 24th 
somite, populate the gut to form the enteric nervous system and smooth muscle (Fig. 6B). 
Concerning guiding cues for trunk neural crest cells partly the same chemokines are involved 
as in cranial neural crest cell migration, however, the presence of the somites results in a dif-
ferent anatomic scene. Additionally, slit/Robo signaling has been identified as important 
guidance mechanism. Neural crest cells express Robo-1 and Robo-2 and avoid cells express-
ing the slit ligands (Jia et al., 2005). In the head, however, migrating neural crest cells express 
slit-1, whereas placode cells express Robo-2, thereby regulating interactions during cranial 
nerve generation. The first wave of neural crest cells is guided on the ventral route, as they are 
repelled laterally by ephrin expression and ventrally attracted by SDF-1/CXCR4 signaling, as 
well as thrombospondin, which promotes neural crest migration and adhesion (Belmadani et 
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al., 2005; Santiago and Erickson, 2002; Tucker et al., 1999). However, as migration occurs 
only through the rostral half of the somite, neural crest cells on the caudal half are repelled by 
Semaphorin-3A (from the dermomyotome) and -3F (from the caudal sclerotome), ephrins, 
and F-spondin (Debby-Brafman et al., 1999; Krull et al., 1997; Schwarz et al., 2009). Some 
neural crest cells accumulate within the somites and cluster to build the dorsal root ganglia 
later on. For the segmental dorsal root ganglia arrangement Neuropilin-1/Semaphorin-3A and 
Neuropilin-2/Semaphorin-3F are required. Neuropilin-1/Semaphorin-3A repulse neural crest 
cells from the intersomitic space and facilitates segmentation of dorsal root gangliogenesis, 
while Neuropilin-2/Semaphorin-3F guides neural crest migration (Roffers-Agarwal and 
Gammill, 2009).        
 
Figure 6: Migration pathways of trunk neural crest cells and migration of vagal and sacral 
neural crest cells towards the gut. (A): The first wave of migrating neural crest cells (left arrows) 
takes the medio-ventral route and migrates between the somites and the neural tube. Those cells will 
form the dorsal root ganglia, and, the cells that migrate further, also the autonomic ganglia. The sec-
ond neural crest cells to leave the neural tube migrate dorsolateral and form the pigment cells of the 
skin. (Adapted from Marmigere and Ernfors, 2007). (B):  neural crest cells from the vagal and sacral 
region populate the enteric gut and form the enteric ganglia as well as enteric smooth muscle. FG: 
foregut; MG: midgut; HG: hindgut. (Adapted from Heanue and Pachnis, 2007). 
 
Neural crest cells that passed the somites are guided towards the aorta, where they will form 
the sympathetic ganglia. This is facilitated by neuregulin secreted by the mesenchyme around 
the dorsal aorta, which attracts ErbB2/B3 expressing neural crest cells and the vascular-
derived neurotrophic factor artemin from peripheral blood vessels, which attracts sympathetic 
precursors expressing the glial-derived neutrophic factor (GDNF) family receptor GFRα 
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(Britsch et al., 1998; Honma et al., 2002). Semaphorin-3a prevents lateral migration to the 
limb and medial migration to the aorta (Kawasaki et al., 2002). Slit-2 repels neural crest cells 
from ventral migration to the endoderm.  
Later the migration pattern of neural crest cells situated at the dorsal part of the neural tube 
changes, as ephrin expression turns from a repellent into an attractant for EphB3 expressing 
melanoblasts and cells migrate laterally through the dermis in order to follow the melanocyte 
lineage (Santiago and Erickson, 2002). In addition, neural crest cells are now inhibited in their 
ventral migration through the somites by Neuropilin-1/Semaphorin 3a signaling (Roffers-
Agarwal and Gammill, 2009).  
As neural crest cells express integrins, which are receptors for fibronectin and laminin (Kil et 
al., 1998; Monier-Gavelle and Duband, 1997) it is not surprising that on all neural crest mi-
gration routes extracellular matrix proteins are found, which are essential for neural crest mi-
gration without directly guiding them. Particularly those include fibronectin, laminin and col-
lagen (Duband and Thiery, 1987; Newgreen and Thiery, 1980).  
 
1.2.4 Environmental cues for in vitro neural crest cell differentiation  
In vitro neural crest differentiation has been extensively studied on mouse cells, by dissecting 
the neural tube, plating it on an appropriate substrate and allowing neural crest cells to de-
laminate and migrate. Using these in vitro neural crest cultures, researchers were able to per-
form extensive studies on identifying cues for directed differentiation of isolated neural crest 
cells. In order to do this, it is important to internalize the events leading to neural crest differ-
entiation during in vivo embryonic development. Neural crest cells staying close to the neural 
tube form the dorsal root ganglia. In vitro differentiation showed that neural crest cells require 
the presence of the neural tube to enter the sensory neuron lineage. However, researchers 
were able to substitute the presence of the neural tube by application of Wnt to gain sensory 
neurons. The differentiation towards autonomic neurons could be facilitated by application of 
BMP4, which is segregated in vivo by the dorsal aorta to which the sympathetic neuron pre-
cursors migrate towards (Reissmann et al., 1996; Schneider et al., 1999; Shah et al., 1996). 
For the differentiation towards the peripheral glia type Schwann cells NRG-1 was identified 
as a powerful glial instructor (Leimeroth et al., 2002; Meyer et al., 1997; Shah et al., 1994). 
For mesenchymal differentiation of neural crest cells commonly the differentiating effect of 
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fetal calf serum (FCS) is used. It has been shown that smooth muscle differentiation is addi-
tionally enhanced by application of TGF-β (Shah et al., 1996; Trainor et al., 2002). Moreover 
cranial neural crest cells give rise to cartilage, bone, as well as to fat cells of the face, but also 
of the trunk. Even though in vivo trunk neural crest cells do not give rise to mesenchymal de-
rivatives, they could be differentiated into skeletogenic phenotypes when cultured in the ap-
propriate conditions, thereby exhibiting plasticity (McGonnell and Graham, 2002). Concern-
ing the differentiation of pigment cells, it has been shown that stem cell factor (SCF; also 
called steel factor) supports survival, proliferation and also final differentiation of melano-
cytes in vivo (Kunisada et al., 1998). Furthermore it has been shown that the interaction of 
endothelin-3 with the endothelin-B receptor is essential for the development of melanocytes. 
Those factors have already been used to generate melanocytes from murine ES cells (Fang et 
al., 2006; Motohashi et al., 2007; Yamane et al., 1999) and hES cells (Fang et al., 2006). 
 
 
 
Figure 7: Differentiation 
potential of primary neural 
crest cells from the mouse. 
Murine primary neural crest 
cells are obtained by plating of 
the explanted embryonic neu-
ral tube on fibronectin, after 20 
hours neural crest cells mi-
grate out of the neural tube, 
which is than removed by 
scraping. Clonal plated neural 
crest cells give rise to smooth 
muscle upon TGF-β treatment, 
autonomic neurons are derived 
by application of BMP2, treat-
ment with NRG-1 yields pe-
ripheral glia cells, and sensory 
neurons are obtained by appli-
cation of Wnt1. Treatment with 
FCS leads to development of a 
mixed clone. (Adapted from 
Shakhova and Sommer, 2010).  
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1.2.5 Differentiation of neural rosettes and neural crest cells from 
pluripotent stem cells 
Pluripotent stem cells have been extensively used for the study of CNS development. Neural 
differentiation of hES cells as well as iPS cells is efficiently achieved by an intermediate neu-
ral rosette step. Neural rosettes are made of radial arranged columnar cells that show similar 
properties to the neural tube, and are therefore often considered as neural tube-like structures 
(Elkabetz et al., 2008; Li et al., 2005). When isolated, they give rise to rosette-type neural 
stem cells (Elkabetz et al., 2008; Koch et al., 2009; Zhang et al., 2001). Those neural stem 
cells show high proliferation rates and are tripotent as they differentiate into neurons, astro-
cytes and oligodendrocytes.  
Typically, either an embryoid body (EB) step or a stromal co-cultivation is used to initiate 
neural differentiation and to gain neural rosettes. The neural inducing effect of stromal cells, 
so called stromal-derived-inducing-activity (SDIA) is largely unexplored. As the cultivation 
of hES cells in stromal cell conditioned medium leads to an inducing effect, it is likely that 
secreted factors are responsible for the phenomenon (Vazin et al., 2008). The application of 
BMP suppresses the neural inducing effect of stromal cells on mouse ESCs, indicating that 
inhibition of BMP is relevant for the SDIA. However, it is shown in the same publication that 
also the co-cultivation of fixed stromal cells can induce neural differentiation, so probably 
surface bound components are also of importance (Kawasaki et al., 2000). Due to the uniden-
tified underlying mechanism and the fact that they are animal-derived, stromal cells are, de-
spite their strong neuralizing effect, unfeasible in a therapeutic context.  
EBs are formed by aggregation of free-floating pluripotent stem cells and withdrawal of 
pluripotency-sustaining extrinsic factors. The differentiation of this paradigm is undirected, so 
that all three germ layers are generated. Growth factor application in order to direct differen-
tiation is difficult, as the proper dispersal in the aggregate is not granted. Furthermore EBs are 
inapplicable for long term cultivation, as they loose shape and build vacuoles. Many protocols 
therefore use the initial differentiation to EBs, but then switch to an adherent culture by plat-
ing the aggregates (Zhang et al., 2001).  
As neural rosettes and the neural stem cells derived thereof display in vitro properties of the 
neural tube, it is obvious that neural crest cells are found in close relation to this mimicked 
developmental step. SDIA-based protocols have been used to generate neural crest cells, ei-
  
 
 
Introduction 
 
20 
 
ther through an intermediate rosette step (Lee et al., 2007) or direct differentiation on the 
stromal cell layer (Hotta et al., 2009; Pomp et al., 2005b). Two protocols also use EB-based 
differentiation paradigms to either FACSort neural crest cells directly from the EB (Jiang et 
al., 2009) or derive them from isolated neural rosettes obtained by plating of EBs (Colleoni et 
al., 2010).   
 
1.2.6 Therapeutic potential of pluripotent stem cell-derived neural 
crest cells  
Due to the unavailability of human embryonic tissues, the research on human neural crest 
development was largely restricted so far. Few data exist on primary human neural crest 
(Betters et al., 2010; O'Rahilly and Muller, 2007; Thomas et al., 2008). Recently, hES cells 
have been discovered as source for neural crest cells. Due to their ability to self-renew, they 
offer an inexhaustible pool of parental cells. Basic research on neural crest development helps 
us to understand the early events of embryonic development in the healthy human, but also 
the aberrations occurring in neural crest-related disorders, termed neurocristopathies. Among 
those are the neural crest related cancers, like Neuroblastoma, Schwannoma, and Melanoma, 
which are the most aggressive cancer cell types. Neural crest EMT and migration resembles a 
programmed version of the unprogrammed invasion occurring during metastasis. Therefore, 
the study on this highly proliferative cell population is of high interest in cancer research. Due 
to the complex impact of neural crest cells on the development of vertebrates, numerous dis-
eases are known that are related to neural crest malfunction. Examples are Hirschsprung’s 
disease and Charcot-Marie-Tooth disease, affecting primarily the peripheral nervous system, 
DiGeorge and CHARGE syndrome, which result from cranial and cardiac neural crest dys-
function. In the future cell culture models might be used to generate and test medical treat-
ment. The possibility to derive large cell numbers of human neural crest derivatives offers 
vast prospects for high throughput screening of compounds. For example, in vitro cultivated 
sensory neurons could be of great value in the development of pain medication. Additionally, 
the generation of patient-specific iPS cells may lead to exciting disease models for neurocris-
topathies. First attempts in this direction have shown that patient-specific iPS cell-derived 
neural crest cells can serve as disease model for the neural crest-related disorder familiar dys-
trophy (Lee et al., 2009).  
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1.3 Aim of the project 
The neural crest is a transient embryonic cell population that contributes to a vast amount of 
different cell types of the vertebrate body. Its emergence, migration and differentiation have 
been studied extensively in animal models, but many aspects of this versatile population re-
main unrevealed. Due to the inaccessibility of human embryonic primary tissue, the studies on 
neural crest development are highly limited. This project aimed at the investigation of human 
neural crest development using hES cells as inexhaustible cell source. Whereas the occurrence 
of neural rosettes in differentiating hES cell cultures is a well-known phenomenon, less is 
known about the co-appearance of neural crest cells. The aim of this work was to assess 
whether hES cell-derived neural rosettes exhibit dorsal-ventral organization and thereby re-
semble a primitive form of the neural tube. It should be investigated whether neural crest cells 
emerge from these neural tube-like structures. After successful characterization of potential 
neural crest cells on mRNA and protein level, a purified human neural crest cell population 
should be established, which multipotency should be proven by successful differentiation into 
multiple neural crest derivatives. Having established a stable cell culture model, a further aim 
was to show the prospects to what extend this model could be used to investigate human neu-
ral crest development. Therefore the shifting expression of cadherins, as observed during 
EMT in vivo, should be investigated during the in vitro delamination process of human neural 
crest cells.  
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2.1 Materials 
Tab. 1: List of equipment 
Equipment Article  Manufacturer Registered Office 
Chemiluminescence 
detection 
 
Chemidoc XRS Bio-rad Laborato-
ries 
Munich 
Agagel Mini Biometra Göttingen 
Agagel Midi-Wide Biometra Göttingen 
Electrophoresis 
ProteanIII MiniGel System Bio-rad Laborato-
ries 
Munich 
Thermocycler T3 Thermocycler Biometra Göttingen 
Incubators for cell cul-
ture 
Heracell Biometra Göttingen 
Microscopes Axiovert 40C 
Axiovert 200M 
Stemi 2000-C 
Carl Zeiss Jena 
Microscope camera AxioCam MRm Carl Zeiss  Jena 
pH-Meter CG840 Schott Mainz 
Photometer NanoDrop Peqlab Erlangen 
Standard PowerPack P25 Biometra Göttingen Power supply for elec-
trophoresis 
PowerPack 200 Bio-rad Laborato-
ries 
Munich 
Sterile workbenches Herasafe Heraeus Hanau 
 
Tab. 2: List of laboratory plastic ware 
Laboratory plastic ware Cat. No. Manufacturer Registered Office 
4-well culture dishes 179820 Nunc Wiesbaden 
6-well culture dishes 140685 Nunc Wiesbaden 
12-well culture dishes 150682 Nunc Wiesbaden 
Cellstar TM 175 cm2 flasks 660175 Greiner Bio-One Solingen 
Culture dishes ∅ 3,5 cm 353001 BD Biosciences Heidelberg 
Culture dishes ∅ 6 cm  353004 BD Biosciences Heidelberg 
2 Materials and Methods 
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Culture dishes ∅ 10 cm 353003 BD Biosciences Heidelberg 
Culture dishes ∅ 15 cm 93150 MIDSCI St. Louis, USA 
EB culture dishes ∅ 6 cm 083878 Nunc Wiesbaden 
Nitrocellulose membranes  4684.1 Carl Roth GmbH Karlsruhe 
PCR strip tubes - 0.2 mL 81-38440 PEQLAB Erlangen 
Round bottom tubes - 12x75mm 352054 BD Biosciences Heidelberg 
Serological pipettes (25, 10, and 5 mL) 
356525 
356551 
356543 
BD Biosciences Heidelberg 
Syringes - 20 mL 300296 BD Biosciences Heidelberg 
Syringe filter - 0.2 µm PN 4612 PALL Dreieich 
Tubes - 0.5 mL 667204 Greiner Bio-One Solingen 
Tubes - 1.5 mL 616201 Greiner Bio-One Solingen 
Tubes - 15 mL 227261 Greiner Bio-One Solingen 
Tubes - 50 mL 188271 Greiner Bio-One Solingen 
Cryovials - 1 mL  375353 Nunc Wiesbaden 
Cryovials - 1.8 mL 375418 Nunc Wiesbaden 
 
Tab. 3: List of chemicals, media and supplements 
Chemicals, media and supplements Cat. No. Manufacturer Registered Office 
2-Mercaptoethanol 13256 Invitrogen Karlsruhe 
2-Phospho-L-ascorbic acid trisodium 
salt 49752 Sigma-Aldrich München 
3-Isobutyl-1-methylxanthine I5879 Sigma-Aldrich München 
Agarose 35-1020 PEQLAB Erlangen 
Alcian Blue 236551 Sigma-Aldrich München 
Alizarin red A5533 Sigma-Aldrich München 
Ascorbic acid A4403 Sigma-Aldrich München 
B-27 supplement 17504 Invitrogen Karlsruhe 
B-27 supplement minus Vitamin A 12587 Invitrogen Karlsruhe 
BDNF 248-BD R&D systems Wiesbaden 
Bromphenol blue B0126 Sigma-Aldrich München 
BSA A8806 Sigma-Aldrich München 
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dcAMP D0627 Sigma-Aldrich München 
Collagenase type IV 17104 Invitrogen  Karlsruhe 
CytoconTM buffer II Cy01-01-H07-01-01 Evotec Hamburg 
DABCO 0718.2 Carl Roth GmbH Karlsruhe 
Dexamtehasone D1756 Sigma-Aldrich München 
DNA ladder (100bp) SM0241 Fermentas Leon-Rot 
dNTPs 20-2012 PEQLAB Erlangen 
DMEM/F12 (1:1) 11320 Invitrogen Karlsruhe 
DMEM high glucose 41965 Invitrogen Karlsruhe 
DMSO D2650 Sigma-Aldrich München 
D-PBS 14190 Invitrogen Karlsruhe 
EDTA E6511 Sigma-Aldrich München 
EGF 236-EG-01M R&D systems Wiesbaden 
Ethanol UN 1170 Merk Darmstadt 
Ethidium bromide 2218.1 Carl Roth GmbH Karlsruhe 
FGF2 (hES cell medium) 13256 Invitrogen Karlsruhe 
FGF2 (neural differentiation) 233-FB R&D systems Wiesbaden 
FCS 10270 Invitrogen Karlsruhe 
Fibronectin 33010 Invitrogen Karlsruhe 
Forskolin F6886 Sigma-Aldrich München 
Gelatine G-1890 Invitrogen Karlsruhe 
Glacial acetic acid 1.00063.10011 Merk Darmstadt 
Glucose 49150 Sigma-Aldrich München 
Glycerol G8773 Sigma München 
β-Glycerol phosphate disodium salt 
pentahydrate 50020 Sigma-Aldrich München 
Glycine G7126 Sigma-Aldrich München 
Goat serum donor herd G6767 Sigma-Aldrich München 
HaltTM Protease Inhibitor Single-Use 
Cocktail 78430 
Thermo Scientific/ 
Pierce Biotechnology Rockford, USA 
Horse serum H1270 Sigma-Aldrich München 
Hydrocortisone H0888 Sigma-Aldrich München 
Indomethacin I7378 Sigma-Aldrich München 
Insulin I6634 Sigma-Aldrich München 
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Insulin-transferrin-selenium medium 
supplement I3146 Sigma-Aldrich München 
Knockout-DMEM 10829 Invitrogen Karlsruhe 
Laminin L2020 Sigma-Aldrich München 
L-Glutamine 25030 Invitrogen Karslruhe 
Linoleic Acid-Albumin from BSA L9530 Sigma-Aldrich München 
Matrigel E1270 BD Biosciences Heidelberg 
Methanol 4627.6 Carl Roth GmbH Karlsruhe 
Mowiol 475904 Merck Darmstadt 
N2-supplement 17502 Invitrogen Karlsruhe 
NaHCO3 S5761 Sigma-Aldrich München 
Neuregulin-1 396-HB R&D systems Wiesbaden 
Neurobasal 21103 Invitrogen Karlsruhe 
NGF 256-GF R&D systems Wiesbaden 
Non-essential amino acids 11140 Invitrogen Karlsruhe 
Oil red O0625 Sigma-Aldrich München 
Paraformaldehyde P6148 Sigma-Aldrich München 
Penicillin-Streptomycin 15140 Invitrogen Karlsruhe 
Poly-L-ornithin P2533 Sigma-Aldrich München 
Protein Assay Dye Reagent 500-0006 Bio-Rad Hercules, USA 
Sodium azide S2002 Sigma-Aldrich München 
Sodium pyruvate 11360 Invitrogen Karlsruhe 
Serum replacement 10828 Invitrogen Karlsruhe 
SuperSignal West Femto Maximum 
Sensitivity Substrate 34095 
Thermo Scientific/ 
Pierce Biotechnology Rockford, USA 
GoTaq Flexi DNA Polymerase M8305 Promega Madison, USA 
Transferrin 4452-01 Millipore Billerica, USA 
Tris 1.08382.1000 Merck Darmstadt 
Triton-X100 T8787 Sigma-Aldrich München 
TrypLETM Express 12604 Invitrogen Karlsruhe 
Trypan blue 15250 Invitrogen Karlsruhe 
Trypsin-EDTA (10x) 15400 Invitrogen Karlsruhe 
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2.1.1 Cell lines 
CD1 primary embryonic fibroblasts derived from the mouse strain CD1 
H9.2 hES cell line, Haifa, Israel (Amit et al., 2000) 
I3 hES cell line, Haifa, Israel (Amit et al., 2000) 
 
2.1.2 Cell culture media  
Mouse embryonic fibroblast (MEF) medium 
90%   DMEM high glucose  
10%    FCS, heat inactivated 
2 mM   L-glutamine  
1 mM    Sodium pyruvate  
0.1 mM    Non-essential amino acids  
 
MEF freezing medium 
70%   DMEM high glucose 
20%   FCS, heat inactivated 
10%   DMSO 
 
Human embryonic stem (hES) cell medium 
80%   Knockout-DMEM 
20%   Serum replacement 
1 mM    L-glutamine 
0.1 mM   Non-essential amino acids  
0.1 mM    β-Mercaptoethanol 
4 ng/mL    FGF2 
 
Embryoid body (EB) medium 
80%   Knockout-DMEM 
20%    Serum replacement 
1 mM   L-glutamine 
0.1 mM   Non-essential amino acids  
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N2 medium 
99%   DMEM/F12 1:1  
1%     N2 supplement 
1.6 g/L   D(+)-Glucose 
20 µg/mL   Insulin 
0.1 mg/mL  Transferrin  
 
Neural differentiation medium 
50%    N2 medium 
49%    Neurobasal medium 
1%    B27 supplement 
100 ng/mL  dcAMP 
 
Chondrocyte medium 
MEF medium 
10 µM   Forskolin 
10 ng/mL   FGF2 
100 µM   Ascorbic acid 
 
Osteocyte medium (Fang et al., 2005) 
90%    DMEM/F12 1:1 
10%    FCS 
1x   Insulin-transferrin-selenium medium supplement  
1mg/mL  Linoleic acid BSA 
0.1 µmol/L  Dexamethasone 
0.05 mmol/L  L-ascorbic acid-2-phosphate 
10 mmol/L  β-glycerophosphate 
 
Adipocyte medium (Fang et al., 2005) 
90%   DMEM high Glucose 
10%    Horse serum 
1x    Insulin-transferrin-selenium medium supplement 
1 mg/mL   Linoleic acid BSA 
1 µM/L   Hydrocortisone 
0.5 mM/L   Isobutylmethylxanthine 
60 µM/L   Indomethacin 
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2.1.3 Coating materials 
Poly-L-ornithine (PO) 
0.015 mg/mL in H2O 
Dishes were incubated over night and washed twice with PBS before further treated. 
 
Fibronectin (Fn) 
2 µg/mL in PBS 
Applied on PO-coated dishes. 
 
Laminin (Ln) 
2 µg/mL in PBS 
Applied on PO-coated dishes. 
 
2.1.4 Buffers, solutions and gels for immunological detection methods 
Mounting medium (Mowiol) 
6 mL   H2O  
4.8 mL   Glycerol  
2.4 g    Mowiol  
 stirred overnight, followed by addition of 
12 mL   0.2 M Tris pH 8.5  
 incubated at 50°C till solved, followed by addition of 
45 mg   DABCO 
 cleared from solid matter by centrifugation for 15 min at 5000 rpm. 
 
4% Paraformaldehyde (PFA, 500 mL) 
20 g     PFA 
450 mL   PBS 
3-4    NaOH pellets 
 stirred under the fume hood till dissolved 
  pH adjustment to 7.4  
 filled up to 500 mL 
 
4 x Tris/SDS buffer pH 8.8 
1.5M   Tris-Cl, pH 8.8 
0.4%   SDS 
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4 x Tris/SDS buffer pH 6.8 
0.5M   Tris-Cl, pH 6.8 
0.4%   SDS 
 
SDS-PAGE stacking gel for 5 mL 
2.85 mL  H2O 
0.83 mL  30%/0.8% acrylamide/bis-acrylamide  
1.25 mL  4x Tris/SDS buffer, pH 6.8  
0.075 mL  10% APS 
0.0015 mL   TEMED 
 
SDS-PAGE separating gel (10%) for 10 mL 
4.1 mL  H2O 
3.33 mL  30%/0.8% acrylamide/bis-acrylamide  
2.5 mL  4x Tris/SDS buffer, pH 8.8  
0.075 mL  10% APS 
0.0015 mL  TEMED 
 
Immunoblot (wet) transfer buffer  
25 mM   Tris 
192 mM   Glycine 
20%   Methanol 
 
10x SDS-PAGE electrophoresis buffer 
250 mM  Tris 
1.92 M   Glycine 
1%   SDS 
 
TBS-T 
50 mM  Tris-Cl, pH 7.4 
150mM  NaCl 
0.1%   Tween 20 
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5x SDS loading buffer  
250 mM   Tris-Cl, pH 6.8 
10%    SDS 
50%   Glycerol 
0.02%   Bromophenol blue 
  10% 2-Mercaptoethanol added before use 
 
50xTAE buffer 
2 M   Tris 
50 mM  EDTA, pH 8.0 
1 M   glacial acetic acid 
 
2.2 Methods 
2.2.1  Cell culture and cell separation 
Cells were cultured in humid incubators at 37°C and 5% CO2 at any time. As long as not dif-
ferently stated, cell centrifugation was carried out at 1000 rpm for 5 min. 
 
2.2.1.1 Expansion and inactivation of fibroblasts used in co-culture to main-
tain hES cells 
To maintain the unique features of hES cells, they were cultured on a layer of murine embry-
onic fibroblasts (MEFs), also called feeder cells, which provide nutritional and cellular sup-
port to the pluripotent cells. Prior to co-cultivation, MEFs had to be expanded and irradiated 
in order to mitotically inactivate them. Fibroblasts were isolated from CD1 mouse embryos 
(E13.5-E14.5), mycoplasma tested, and cryopreserved for storage. For expansion, fibroblasts 
were thawed in a 37°C water bath. The cell suspension was transferred to 10 mL of MEF me-
dium. The cryovial was rinsed with 1 mL of medium. After centrifugation the cell pellet was 
resuspended and cells were plated on three 15 cm dishes in a volume of 20 mL MEF medium 
each and transferred to the incubator. As soon as the cells were grown to confluency and 
showed a compact morphology (after 4-5 days), the dishes were washed with 10 mL of PBS. 
Afterwards 5 mL of Trypsin-EDTA was added to each dish, followed by a short incubation 
time at 37°C until the cells started to detach from the dish when tapped (app. 3 min). The 
Trypsin-EDTA solution was inactivated by adding 5 mL of 10% FCS/DMEM. The cell sus-
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pension was transferred to a 50 mL tube, and the dishes were rinsed with 10% FCS/DMEM. 
After centrifugation the cell pellet was resuspended and cells were replated on new 15 cm 
dishes at a ratio of 1:3. The fibroblasts were cultivated until passage 3 before they were pre-
pared for irradiation. For that purpose, cells were trypsinized and collected as previously de-
scribed, resuspended in 30 mL of MEF medium and transferred into a 175 cm2 cell culture 
flask. The cells were irradiated using the RS 2000 X-Ray biological irradiator (Rad Source). 
Fibroblasts were irradiated with a single-dose of 15 Gy. Following irradiation the cell suspen-
sion was transferred to a 50 mL tube, and the flask was rinsed with 5 mL MEF medium. After 
centrifugation cells were resuspended in MEF medium and the total cell number was deter-
mined. For this purpose 10 µL of cell suspension were mixed 1:1 with trypan blue, in order to 
exclude dead and therefore blue stained cells from the count. Cells were counted in a Fuchs-
Rosenthal counting chamber. The cell number was calculated as follows:  
Average cell count per square x 5 x 2 x 104 = cells/mL 
 5 squares resemble 1 µL 
 2 is the dilution factor caused by dilution with trypan blue 
According to the determined cell number, cells were diluted and frozen in MEF freezing me-
dium at a final concentration of 2.4 x 106 cells/mL. The cryovials were embedded in Styro-
foam boxes and stored at -80°C for 1-2 days before transferring them to liquid nitrogen for 
long-term storage. 
 
2.2.1.2 Cultivation of hES cells 
One day prior to thawing of hES cells, irradiated MEFs were thawed in MEF medium at a 
density of 1.2 x 106 cells/mL per 6-well dish, which were pre-coated with 0,1% Gelatine 
(solved in H2O) for 20 min. hES cells were thawed in a 37°C water bath. The cell suspension 
was transferred to 5 mL of hES cell medium and the cryovial was rinsed with 1 mL of me-
dium before the cell suspension was centrifuged at 800 rpm for 3 min. Cells were frozen at a 
density of two wells per cryovial and were therefore also seeded on two wells of a MEF 6-
well dish in 2 mL hES cell medium per well. The medium was changed every day. Every 4-5 
days, when the hES cell colonies exceeded in size, cells were splitted on new feeder cells at a 
ratio of 1:2 – 1:5, depending on density of colonies. hES cell colonies were enzymatically 
detached by incubation with 1 mL/well collagenase (1 mg/mL) for 1 hour. Using this method, 
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the hES cell colonies detach from the feeder layer, while the feeder cells largely remain on the 
culture dish. 1 mL of hES cell medium was used to carefully rinse the colonies from the well. 
The cell suspension was centrifuged at 800 rpm for 3 min. Afterwards the cell pellet was gen-
tly resuspended in 1 mL of hES cell medium using the tip of a 1000 µL pipette to disassociate 
the colonies. This is a crucial step of the protocol, as the colonies differentiate when they are 
too large and do not re-plate when they are too small. 
For feeder-free cultivation of hES cells, as it was done prior to RNA isolation, hES cells were 
splitted as described above and re-plated feeder-free on matrigel-coated dishes in fibroblast 
conditioned medium supplemented with 4 ng/mL FGF2. Conditioned medium was prepared 
beforehand by cultivation of fibroblasts in hES cell medium, which was preserved with the 
daily medium change. hES cells were cultivated 4-5 days with a daily medium change before 
they were harvested for RNA isolation. 
 
2.2.1.3 Establishment of the neural crest delamination model 
hES cells were forced into spontaneous differentiation by aggregation to free floating EBs. 
For this purpose, cells were enzymatically treated as described above, but here the disassocia-
tion of the colonies was avoided. After centrifugation at 800 rpm for 3 min, colonies were 
resuspended in EB medium and seeded on 10 cm cell culture dishes. One 6-well plate yielded 
one 10 cm dish. EBs were cultivated in 8 mL of EB medium per dish. The next day the me-
dium containing the free-floating aggregates was collected in a tube, aggregates were allowed 
to settle by gravity, and the supernatant was discarded and replenished with fresh EB medium. 
Aggregates were transferred on 10 cm Petri dishes, which prevent attachment of aggregates. 
The first day of pre-cultivation on cell culture dishes will remove remaining fibroblasts from 
the culture, which were previously inadvertently detached by collagenase treatment. The EB 
medium was replenished every other day. After 5 days of culture, EBs were plated on PO/Fn-
coated cell culture dishes. One EB containing Petri dish was plated on two 10 cm cell culture 
dishes. The next day, when EBs attached to the dish, medium was changed to N2 medium 
containing 20 ng/mL FGF2 and 2.5 µg/mL Fn. Medium was replenished every other day. Cell 
cultures were processed for analysis or neural crest cell isolation after 7-9 days of cultivation 
in N2 medium. 
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2.2.1.4 Isolation of neural crest cells by FACS 
One approach to isolate the p75NTR-positive cell population from the heterogenous cultures 
of plated EBs is immuno-based FACSorting. Therefore cells were detached with TrypLETM 
Express, which is less harsh than Trypsin-EDTA, centrifuged and exposed to blocking buffer 
(Cytocon + 0.1% BSA) for 15 minutes. Cells were centrifuged and subsequently exposed to 
anti-p75NTR (DAKO) diluted 1:500 in blocking buffer for 15 minutes. The tube was filled 
with 10 mL PBS, centrifuged and exposed to the secondary antibody Cy5 (Dianova) diluted 
1:500 in blocking buffer for 15 minutes. After one washing step with PBS the cells were cen-
trifuged and subsequently diluted in Cytocon buffer+0.02% DNAse to gain a cell density of 
approximately 5x106/mL. Additionally an unstained control was prepared, as well a secondary 
antibody control. Just before sorting the cells were filtered through a 40 µm nylon mesh in a 
12x75 mm round bottom tube. 0.2 mg/mL of propidium iodide was added to stain for dead 
cells. The cell sorting was done in cooperation with the Flowcytometry Core Facility of the 
Institute of Molecular Medicine and Experimental Immunology, University of Bonn. Sorting 
was performed using the FACS Vantage SE with FACSDiVa option (BD Biosciences). 
Sorted cells were replated on PO/Fn/Ln-coated cell culture dishes in N2 medium containing 
20 ng/mL FGF, 20 ng/mL EGF, 0.1% B27, 100 U Penicillin and 100 µg Streptomycin.  
 
2.2.1.5 Isolation of neural crest cells by manual picking 
Crescent-shaped aggregates were identified and picked using a stereomicroscope (STEMI 
2000C, Carl Zeiss) in the sterile environment of a horizontal lamina flow hood. Aggregates 
were encircled using a sterile cannula and gathered with a pipette tip. The free-floating aggre-
gates were transferred to a PO/Fn-coated cell culture dish containing N2 medium supple-
mented with 20 ng/mL FGF, 20 ng/mL EGF and 0.1% B27 and cultivated for 24 hours. The 
replated aggregates, as well as the cells migrating thereof, were detached by treatment with 
TrypLETM Express, gently trituated with a glass pipette and replated as monolayer on PO/Fn-
coated cell culture dishes. Cells were passaged using TrypLETM Express every 3-4 days in a 
1:3 ratio. 
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2.2.1.6 Differentiation of manually isolated neural crest cells 
For differentiation, manually isolated neural crest cells not older than passage 3 were used.   
Peripheral neurons 
For neuronal differentiation cells were plated on PO/Fn/Ln-coated dishes and cultivated in 
neural differentiation medium supplemented with 20 ng/mL nerve growth factor (NGF), 10 
ng/mL brain-derived neutrophic factor (BDNF) and 100 µM ascorbic acid. Cells were fixed or 
harvested for RNA isolation after three weeks of differentiation.   
Schwann cells 
For differentiation towards Schwann cells, cells were plated on PO/Ln/Fn-coated dishes and 
cultivated in N2 medium containing 1% B27, 10 ng/mL FGF2, 5 µM Forskolin and 20 ng/mL 
neuregulin-1 (NRG-1). After 2 weeks in this Schwann cell promoting proliferation medium, 
FGF2 was withdrawn to induce terminal differentiation. Cells were fixed or harvested for 
RNA isolation after additional two weeks of terminal differentiation. 
Mesenchymal cell types 
Cells were differentiated into smooth muscle, chondrocytes, osteoblasts and adipocytes. For 
all differentiation paradigms, cells were cultivated on Matrigel-coated dishes. Cells were cul-
tivated either in mesenchymal medium, chondrocyte medium, adipocyte medium or osteoblast 
medium for at least 3 weeks prior to fixation or processing for RNA isolation.  
 
2.2.2 Electrophysiological recordings 
All measurements were carried out in collaboration with Jaideep Kesavan. Neural crest-
derived neurons differentiated for 6-8 weeks in vitro were selected for experiments. Whole 
cell current-clamp and voltage-clamp recording was carried out with Axopatch- 200B ampli-
fier (Molecular Devices, USA) that was interfaced by an A/D-converter (Digidata 1440, Mo-
lecular Devices, USA) to a PC running PClamp software (Version 10, Molecular Devices). 
Pipette electrodes (GB150F-8P, Science products, Germany) were fabricated using a vertical 
puller (Narishige PC-10, Japan) and fire-polished (final tip resistances 2–4 MΩ). All record-
ings were performed at room temperature in a bath solution containing (in mM): 140 NaCl, 5 
KCl, 2 CaCl2, 0.8 MgCl2, 10 Hepes and 10 glucose (pH 7.2; osmolality 310–320 mOsm). For 
most recordings of membrane potential or current, the patch pipette contained the following 
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(in mM): 120 potassium gluconate (C6H11O7K), 20 KCl, 10 NaCl, 10 EGTA, 1 CaCl2, 4 Mg 
ATP, and 0.4 Na GTP, 10 Hepes and 0.2% biocytin (pH 7.2, osmolality 280–290 mOsm). For 
some voltage-clamp recording, another pipette filling solution was used (in mM): 120 potas-
sium fluoride, 20 KCl, 10 NaCl, 10 EGTA, 1 CaCl2, 4 Mg ATP, and 0.4 Na GTP, 10 Hepes 
and 0.2% biocytin (pH 7.2, osmolality 280–290 mOsm). After measurements, cells were fixed 
in 4% PFA and prepared for immunofluorescence analysis. Biocytin-filled neurons were iden-
tified via application of Texas Red Avidin D. For details on staining procedures see 2.2.4. 
 
2.2.3 Time-lapse imaging 
In order to visualize the dynamic processes of the developmental events, a plated EB and an 
isolated crescent-shaped delaminate were monitored for several hours using time-lapse imag-
ing. Time-lapse imaging was conducted using the inverse microscope Axiovert 200M (Carl 
Zeiss). The climate in the incubation chamber was adjusted to 37°C and 5% CO2. The Open-
lab software from Improvision was programmed to issue a command to the camera (Axio-
cam MRM, Carl Zeiss) every five minutes. In this way the objects were monitored for 72 
hours. The resulting pictures were merged to time-lapse movies using Quicktime 7.6.4. 
Subsequently to the recording of pictures, cells were fixed in 4% PFA and prepared for im-
munofluorescence analysis. For details on staining procedures see 2.2.4. 
 
2.2.4 Immunocytochemical analysis 
Cells were fixed with 4% PFA for 10 minutes. Afterwards cells were washed three times with 
PBS and subsequently incubated in blocking solution (5% NGS in PBS) for 15 minutes, fol-
lowed by incubation with primary antibody for at least 2 hours (details are given in Table 4, 
diluted in blocking solution). Cells were then washed three times with PBS and incubated 
with the appropriate secondary antibody for 45 minutes (details are given in Table 5, diluted 
in PBS). Cell nuclei were counter-stained applying DAPI staining solution (details are given 
Table 5, diluted in H2O) for 1 minute. After washing with PBS cells were covered using 
Moviol and a cover slip for microscopic analysis.   
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Tab. 4: List of primary antibodies used for immunofluorescence analysis 
Antibody Dilution Cat. No. Manufacturer Registered Office 
Mouse anti-AP2α 1:10 5E4 Supernatant Developmental Studies Hybridoma Bank Iowa, USA 
Mouse anti-Brn3a 1:50 MAB1585 Millipore Billerica, USA 
Mouse anti-HNK1 1:20 Kind gift from B. Schmitz 
Mouse anti-p75NTR 
(p75) 1:100 M3507 DAKO Hamburg 
Mouse anti-PAX3 1:300 Pax3 Concen-trate  
Developmental Studies 
Hybridoma Bank Iowa, USA 
Mouse anti-PAX7 1:300 Pax7 Concen-trate 
Developmental Studies 
Hybridoma Bank Iowa, USA 
Mouse anti-SHH 1:25 5E1 Developmental Studies Hybridoma Bank Iowa, USA 
Mouse anti-SMA 1:125 IS611 DAKO Hamburg 
Mouse anti-SOXE 1:50 Kind gift of M. Wegner (Schmidt et al., 2003) 
Mouse anti-TH 1:1,000 T1299 Sigma-Aldrich München 
Rabbit anti-GFAP 1:1,000 IS524 DAKO Hamburg 
Rabbit anti-L1CAM 1:300 Kind gift from M. Schachner 
Rabbit anti-N-cadherin 1:200 BTA7 R&D systems Wiesbaden 
Rabbit anti-Peripherin 1:300 AB1530 Millipore Billerica, USA 
 
Tab. 5: List of secondary antibodies and fluorochromes used for immunofluorescence 
analysis 
Secondary antibody/Fluorochrome Final  concentration Cat. No. Manufacturer Registered Office 
Alexa Fluor® 555 goat anti-mouse 
IgG (H+L) 
2 µg/mL 
 
A21424 Invitrogen Karlsruhe 
Alexa Fluor® 488 goat anti-rabbit 
IgG (H+L) 
2 µg/mL A11008 Invitrogen  Karlsruhe 
DAPI staining solution  2 µg/mL D9542 Sigma-Aldrich München 
Texas Red® Avidin D 10 µg/mL A2006 Vector Labora-
tories 
Burlingame, USA 
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2.2.5 Histological stains 
For the identification of adipocytes, chondrocytes, and osteoblasts histological staining meth-
ods were used. Oil red staining was done by exposing fixed cells to Oil red O solution (0.5% 
Oil red O in 60% Isopropanol/dH2O) for 15 minutes. Alizarin red staining solution (2% aliza-
rin red in dH2O, pH4.1) was applied for 5 minutes and alcian blue (1% alcian blue in 0.5% 
acetic acid/dH2O, pH3.1) for 5 minutes. See Table 3 for information on suppliers of dyes. Be-
fore and after application of the staining solutions, cells were washed with dH2O.  
 
2.2.6 Molecular analysis 
RNA was extracted from cell pellets using RNeasy Mini Kit including a DNase digestion 
step with RNase-Free DNase Set (both Quiagen) according to the instructions given by the 
manufacturer. RNA quality and quantity was measured using the UV-Vis spectrophotometer 
NanoDrop ND-1000 (PEQLAB).  
 
2.2.6.1 Reverse transcriptase- polymerase chain reaction 
For reverse transcriptase-polymerase chain reaction (RT-PCR) transcription to cDNA was 
performed using iScriptTM cDNA Synthesis Kit (Bio-Rad Laboratories). The instructions pro-
vided by the manufacturers were obeyed. According to the obtained quantity, the cDNA was 
diluted with nuclease-free H2O to yield a concentration of 100 ng/µL. PCR was conducted by 
using GoTaq green flexi (Promega). Sequences, product sizes and annealing temperatures of 
used primer pairs are given in Table 6. Primer sequences were either obtained from the publi-
cations cited or designed from sequences available at the NCBI GenBank database by using 
the primer Blast. Primers were synthesized by Invitrogen. PCR reactions were prepared as 
described in Table 7. The GoTaq polymerase was added just before starting the PCR reaction. 
PCR parameters used for amplification are shown in Table 8. For each primer pair a negative 
control (without template) and an appropriate positive control (Table 9) were conducted. PCR 
products were analyzed for their sizes using agarose gel electrophoresis. 
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Tab. 6: Details of used primer pairs 
Primer Sequence Product size  
[bp] 
Annealing 
Temperature 
 [°C] 
ACAN 
(Aggrecan) 
s- CACTGTTACCGCCACTTCCC 
as- ACCAGCGGAAGTCCCCTTCG 
(Lee et al., 2007) 
184 56 
ACTA2 
(SMAα) 
s- CTGTTTTCCCATCCATTGTGG 
as- GCAACACGAAGCTCATTGTAG 
(Lee et al., 2007) 
205 54 
ACTG2 
(SMAγ) 
s- ACCCTCGGTGCTCCAGTCCC 
as-CACGGCCAGCCAAGTCCAGG 
596 65 
ASCL1 s- CGGCCAACAAGAAGATGAGT 
as- TGGAGTAGTTGGGGGAGATG 
150 60 
B3GAT1  
(HNK1) 
 
s- GCAAGAAGGGCTTCACTGAC 
as- GCCCCCAGAATAGAAAGGAG 
(Jiang et al., 2009) 
165 56 
CNP s- GGCAGAGGAGTACGCTCAAC 
as- GTTGCTGCTCGCTTAACTCC 
128 60 
COL2A1 
(Collagen 
type II α 1) 
s- ATGATTCGCCTCGGGGCTCC 
as- CATTACTGGGAACTGGGCGC  
(Lee et al., 2007) 
390 58 
EGR2 
(KROX20) 
s- TTGACCAGATGAACGGAGTG 
as- CAGAGACGGGAGCAAAGC 
108 60 
FOXG1 s- CCCTCCCATTTCTGTACGTTT  
as- CTGGCGGCTCTTAGAGAT  
204 60 
GAPDH s-  ACGACCCCTTCATTGACCTCAACT  
as- ATATTTCTCGTGGTTCACACCCAT 
320 60 
GBX2 s- CTCGCTGCTCGCCTTCTC  
as- GCCAGTCAGATTGTCATCCG  
169 60 
HAND2 s- AGAAGACCGACGTGAAAGAGGAGA 
as-ACACGGGAGTGTCCTCTTCGTATT 
(Pomp et al., 2005b) 
400 60 
HOXA2 s- TTCAGCAAAATGCCCTCTCT 
as- TAGGCCAGCTCCACAGTTCT 
176 60 
HOXB2 s- TTTAGCCGTTCGCTTAGAGG 
as- CGGATAGCTGGAGACAGGAG 
173 60 
  
   
 
Materials and Methods 
 
39 
 
L1CAM 
 
s- GAGAGTGACAACGAGGAG 
as- GCCAATGAACGAACCATC 
144 60 
MNX1 
(HB9) 
s- GGTGACCATGAGCGAGGTG 
as- CCTAAGATGCCCGACTTCAAC 
174 60 
NGFR 
(p75NTR) 
s- CCCCCTTCTCCCACACTGCTA 
as- GAACCCCAAACCTGACTCCAT 
(Pomp et al., 2005a) 
591 60 
NKX2-2 s- TCTACGACAGCAGCGACAAC 
as- TTGTCATTGTCCGGTGACTC 
154 60 
NTRK1 
(TrkA) 
s- CCCTGCTCATGGTCTTTGA 
as- GGTGCACAAAATGCAGACC 
195 60 
NTRK2 
(TrkB) 
s- AAGGTGTTGGCCCAGCCTCCGTTAT 
as-GTCAGTTCCGTGGGCGGGTT 
559 60 
NTRK3 
(TrkC) 
s- AGCACTGCATCGAGTTTGTG 
as- AGTGGGTTTTTGGCAATGAG 
(Jiang et al., 2009) 
199 60 
OTX2 s- TGCAGGGGTTCTTCTGTGAT  
as- AGGGTCAGAGCAATTGACCA  
234 60 
PAX3 s- GAACACGTTCGACAAAAGCA 
as- GCACACAAGCAAATGGAATG  
(Koch et al., 2009) 
160  
 
60 
PAX7 s- AAGATTCTTTGCCGCTACCA  
as- CACAGTGCTTCGGTCACAGT  
(Koch et al., 2009) 
192 60 
PHOX2B s- AGTCCTGTATGGCTGGGATG 
as- GTACGGACTGCTCTGGTGGT 
191 60 
POU4F1 
(BRN3A) 
s- ACTCAGCCAGAGCACCATCT 
as- CAGAGAATGGGTGGAGGAAA 
508 60 
PRPH 
(Peripherin) 
 
s- TTGAGTTCCTCAAGAAGCTGCACG 
as- CACCTCAGGCACAGTCGTCTTTAT 
(Pomp et al., 2005a) 
605 60 
SHH s-GCTGATGACTCAGAGGTGTAAGGACAA 
as-TCGCGGTCAGACGTGGTGAT 
 
174 62 
SNAI1 s- ACCCCACATCCTTCTCACTG 
as- TACAAAAACCCACGCAGACA 
 
217 60 
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SNAI2 s- GCGATGCCCAGTCTAGAAAA 
as- GCAGTGAGGGCAAGAAAAAG 
203 60 
SOX10 s- AGCCCAGGTGAAGACAGAGA 
as- AGGAGAAGGCCGAGTAGAGG 
201 60 
TFAP2A 
(AP2α) 
s- TCCCTGTCCAAGTCCAACAGCAAT 
as- AAATTCGGTTTCGCACACGTACCC 
(Pomp et al., 2005a) 
396 60 
TH s- CAGTTCTCGCAGGACATTG 
as- CGTCTGGTCTTGGTAGGG 
243 60 
 
 
Tab. 7: PCR reaction mix 
Ingredient Final concentration Volume [µL] in 25 µL 
reaction volume 
cDNA 100 ng 1 
GoTaq PCR buffer (10x) 1x 2.5 
MgCl2 (50 mM) 1.5 mM 0.75 
dNTPs (dGTP, dATP, dTTP, dCTP; 100 mM) 0.4 mM 0.1 
Primer mix (forward and reverse, each 10 µM) 0.4 µM  2  
GoTaq DNA polymerase 1 unit 0.1 
H2O  18.55 
 
 
Tab. 8: PCR reaction steps 
Process Temperature [C°] Time [min] 
Initial denaturation 94 5 
Denaturation 94 1 
Annealing Depended on primer (Tab.8) 0.5 
Elongation 72 2 
Final elongation 72 10 
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Tab. 9: List of RNA used as template for positive controls for RT-PCRs 
RNA Cat. No. Manufacturer Registered Office 
Human adult brain total RNA 540005 Agilent Technologies Santa Clara, USA 
Human fetal brain total RNA 540157 Agilent Technologies Santa Clara, USA 
Human fetal colon total RNA 540161 Agilent Technologies Santa Clara, USA 
Human whole bone tissue total RNA pM007-r DV Biologics Costa Mesa, USA 
Human Schwannoma biopsy Kind gift from T. Pietsch 
 
2.2.6.2 Agarose gel electrophoresis  
In order to identify the fragment sizes of the obtained RT-PCR products, agarose gel electro-
phoresis was performed. This method is based on the characteristic of DNA to move from the 
negative to the positive pole in an electric current due to the negative charge of its sugar- 
phosphate backbone. For this purpose an agarose solution containing 1.5% agarose in 1xTAE 
buffer was prepared. Solubility of agarose was achieved by heating the solution. After cooling 
ethidium bromide was added to the agarose solution at a concentration of 1µg/mL. Ethidium 
bromide intercalates between the double strands of DNA and changes its absorption spectra. 
Therefore it can be visualized with UV light, which exhibits a wavelength of 254 nm. The 
agarose solution was poured into the gel chamber and a comb was added. After solidifying of 
the agarose gel, 15µL of PCR product was added into each slot. The GoTaq green flexi 
buffer already contains an agarose gel loading buffer. Additionally a DNA ladder was applied 
on each gel, which served as migration standard. An electric current of 80V was applied. Af-
ter 20-30 minutes the gel was analyzed using the Gel doc system (Bio-rad Laboratories). 
 
2.2.6.3 Illumina analysis 
The gene expression analysis was performed in cooperation with Dr. Michael Alexander from 
the Institute of Human Genetics, University of Bonn. hES cell-derived neural crest cells at 
passage 1 were compared to long term propagated neural stem cells derived from hES cells 
(lt-hESNSCs; Koch et al., 2009). Isolated total RNA (see 4.2.4) of cells (lt-hESNSCs and iso-
lated delaminates) was checked for degradation via gel electrophoresis in a BioAnalyzer 2100 
(Agilent Technologies, Waldbronn, Germany) with RNA 6000 nano lab chips following the 
instructions of the manufacturers’ protocol. All used RNA samples showed intact 28S and 
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18S ribosomal RNA signals and a RNA integrity number (RIN) of >9.5. 100 ng of total RNA 
was reverse transcribed into cRNA and biotin-UTP labelled using the Illumina TotalPrep 96-
RNA Amplification Kit (Ambion/Applied Biosystems, Darmstadt, Germany). Labelled cRNA 
was hybridized to Illumina human HT-12 Expression BeadChips v3 using standard protocols 
(Illumina, San Diego, USA). Duplicate analyses were performed for each sample. Fluores-
cence was detected with Illumina iScan (Illumina, San Diego, USA).  
Human HT-12 microarrays interrogate for more than 99.99% of all known human genes (ap-
prox. 25,000 annotated RefSeq and UniGene genes) containing more than 48,000 probes. All 
expression profiles were extracted and average normalized using GenomeStudio software 
(Illumina, San Diego, USA).  
 
2.2.7 Immunoblot analysis 
Cells were either harvested on ice with a cell scraper (plated EBs) or manually isolated under 
the horizontal laminar flow bench (neural crest aggregates and neural tube-like structures) and 
subsequently lysed in RIPA (Radio Immuno Precipitation Assay) buffer supplemented with 
HALT protease inhibitor at 4°C for 30 min. After centrifugation of the lysates at 15.000 rpm 
at 4°C, the supernatant was collected and the protein concentration was measured via Brad-
ford assay. For this purpose, a BSA standard series ranging from 0 to 12 µg was prepared. 4 
µL of sample were diluted with 200 µL PBS. 50 µL of each standard and sample was applied 
in triplicate on a 96 well plate. Protein Assay Dye Reagent (Bio-rad Laboratories) was diluted 
1:4 with PBS and 150 µL of the solution was added to each well. Following approx. 10 min-
utes of incubation, the plate was analyzed at 595 nm using an ELISA plate reader. According 
to their protein concentration, samples were aliquoted to gain a concentration of 50 µg and 
according to the obtained volume diluted with 5x SDS loading buffer Lämmli. Samples were 
either directly used for electrophoresis or stored at -20°C.  
The gel chamber was assembled following manufacturers’ instructions (Mini-PROTEAN 3 
Electrophoresis Cell, Bio-rad Laboratories). First, the separating gel was poured between the 
glass plates and covered with isopropanol. After polymerization (20-30 minutes), the isopro-
panol was removed and the stacking gel was poured on top of the separating gel. The comb 
was set in the stacking gel. After polymerization (20-30 minutes) the comb was removed, 
wells were washed once with ddH2O and the gel was then placed into the electrophoresis 
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chamber. The chamber was filled with 1x running buffer and the samples were heated to 95°C 
for 5 minutes and thereafter centrifuged shortly before the samples were subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 50 µg of total protein was 
loaded per lane of a SDS-PAGE. Additionally, 10 µL of marker containing different proteins 
of defined molecular weight was loaded on one lane. Subsequently, setting a constant voltage 
of 200 V started electrophoresis. The current amounted to 60-70 mA and declined to approx. 
20 mA during the run. SDS-PAGE ran app. 45 minutes.  
Proteins were blotted onto Nitrocellulose membranes applying wet blot technique. For this 
purpose membrane (0.45 micron), filter papers (both Carl Roth GmBH), sponges and the gel 
were soaked in 1x transfer buffer. The blotting chamber (Mini Trans-Blot Transfer Cell, Bio-
rad Laboratories) was assembled following manufacturer’s instructions. Briefly, membrane 
and gel were applied on top of each other and embedded into 2 layers of filter paper and 
sponges on each side. The clip was transferred into the chamber, which was filled with cold 
1x transfer buffer and supplied with a cooling unit. A constant voltage of 100 V was applied. 
The current inclines during the blotting procedure from approx. 250 mA to 350 mA. Blotting 
ran for 1 hour. Subsequently the membrane was dismantled and transferred to TBS-T before 
the staining procedure was continued. Blocking of the membrane with 5% milk powder in 
TBS-T was followed by incubation with primary antibodies according to Table 10 and corre-
sponding secondary antibody as indicated in Table 11. Proteins were detected using Super 
Signal West Femto Substrate in a Chemidoc XRS system (Bio-rad Laboratories). 
 
Tab. 10: List of primary antibodies used for immunoblotting 
Primary antibody Dilution Cat. No. Manufacturer Registered Office 
Mouse anti-E-cadherin 1:1000 ALX-804-201-
C100 
Enzo Life Sci-
ences 
Farmingdale, USA 
Rabbit anti-N-cadherin 1:500 BTA7 R&D systems Wiesbaden 
Rabbit anti-Cadherin-7 1:200 sc-68422 Santa Cruz Bio-
technology, INC. 
Santa Cruz, USA 
Goat anti-Cadherin-11 1:100 AF1790 R&D systems Wiesbaden 
Goat anti-Sox10 1:200 AF2864 R&D systems Wiesbaden 
Mouse anti-p75NTR (p75)-
Biotin 
1:200 130-091-883 Miltenyi Biotec Bergisch Gladbach 
Mouse anti-actin 1:2000 MAB1501 Millipore Billerica, USA 
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Tab. 11: List of secondary antibodies used for immunoblotting 
Secondary antibody Dilution Cat. No. Manufacturer Registered Office 
HRP-conjugated anti-goat IgG 1:500 AP106P Millipore Billerica, USA 
HRP-conjugated anti-mouse IgG 1:1000 7076 Cell Signaling Technology Frankfurt 
HRP-conjugated anti-rabbit IgG 1:500 7074 Cell Signaling Technology Frankfurt 
Streptavidin-HRP 1:1000 P0397 DAKO Hamburg 
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3 Results 
3.1 Formation of neural tube-like structures in plated  
embryoid bodies  
A well-known phenomenon during neural differentiation of hES cells is the formation of neu-
ral rosettes, which have been well characterized in many publications, and are, due to their 
resemblance to the developing neural tube, often referred to as neural tube-like structures. 
They are one source of hES cell-derived neural stem cells. As in vivo neural crest cells de-
laminate from the developing neural tube, the first step of this thesis aimed at the closer inves-
tigation of hES cell-derived neural tube-like structures (Zhang et al., 2007).  
For the differentiation paradigm hES cells were cultivated and proliferated on a fibroblast 
layer. The cells formed compact colonies with defined borders, a typical morphology of pluri-
potent stem cells colonies (Fig. 8A). Spontaneous differentiation of hES cells was induced by 
cultivation in non-adherent cell culture dishes. After 5 days a population of EBs was obtained, 
which exhibited distinct spherical shapes with clear borders (Fig. 8B). The EBs were readily 
plated on Fn-coated cell culture dishes. Following 3 days of cultivation of plated EBs in neu-
ral induction medium containing FGF2 and Fn, first neural rosettes formed in the centre of the 
plated EBs. The structures became more prominent over an additional time period of 5 days in 
culture and displayed typical epithelial morphology with radial arranged columnar cells (Fig. 
8C). Those prominent structures are in the following termed neural tube like-structures. After 
6-7 days in neural induction medium, crescent-shaped aggregates formed in the periphery of 
the plated EBs, which contained the neural tube-like structures in their centers (Fig. 8D).  
 
Figure 8: Outline of cell culture protocol. HES cells were maintained on fibroblast layer (A). 
Withdrawal of fibroblasts and cultivation on uncoated Petri dishes led to formation of EBs (B), which 
were cultivated for 5 days before plating on PO/Fn-coated cell culture dishes. Starting at day 3, neural 
rosette formation was observed in the center of plated EBs, which became more prominent during 
additional 5 days of culture and were termed neural tube like-structures (C). Approx. day 8 after plating 
crescent-shaped aggregates became apparent in the periphery of the EBs, which contained the NTLS 
in their centers (D, asterisk marks the NTLS-containing centre of the EB). NTLS: Neural tube-like 
structures. 
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3.2 Human embryonic stem cell-derived neural tube-like 
structures display a dorsal-ventral patterning 
Neural crest cells delaminate and migrate from the dorsal part of the developing neural tube, 
where the neural folds meet and fuse to form the neural tube. The dorsal-ventral organization 
of the neural tube is accompanied by the expression of distinct transcription factors. Two im-
portant transcription factors that are expressed in the dorsal part of the neural tube are PAX3 
and PAX7. With the aim to investigate whether hES cell-derived neural tube-like structures 
express markers associated with the dorsal neural tube, 6-days-old neural tube-like structures 
were isolated by manual picking and processed in order to isolate RNA. RT-PCR showed that 
hES cell-derived neural tube-like structures strongly express the transcription factors PAX3 
and PAX7 (Fig. 9A). Also, isolated neural tube-like structures expressed SHH. In vivo, SHH is 
secreted by the notochord and from the ventral part of the neural tube, the neural floor plate. 
These RT-PCR data show that markers associated with dorsal-ventral patterning of the neural 
tube can also be found in hES cell-derived neural tube-like structures. 
Next, it should be assessed whether dorsal markers are expressed in certain regions of the hES 
cell-derived neural tube-like structures. Therefore, whole EB cultures were fixed at day 3 and 
day 6 after plating and exposed to specific antibodies. The analysis showed a difference be-
tween young neural rosettes (day 3) and mature neural rosettes (neural tube-like structures, 
from day 6). Young neural rosettes were found to diffusely express both neural plate border 
specifiers PAX3 and PAX7 in the whole structure (Fig. 9B+C). Neural tube-like structures on 
the other hand showed specific staining for PAX3 and PAX7 at the outer edges (Fig. 9D+E 
and magnifications). Also, the ventral marker SHH was found augmented in the lumen of 
some of the neural tube-like structures (Fig. 9F).  
These staining patterns suggest that neural tube-like structures acquire a dorsal-ventral pat-
terning with prolonged time in culture, expressing the dorsal markers PAX3 and PAX7 at 
their outer edges. This data indicates that these primitive in vitro structures indeed resemble 
the neural tube regarding their expression of dorsal markers. Therefore, when aiming at the 
differentiation of neural crest cells from hES cell cultures, these primitive neural tube-like 
structures are a promising source and were consequently further investigated in the next step 
of this thesis.  
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3.3 Neural crest cells accumulate in distinct aggregates in the 
periphery of plated embryoid bodies  
Taking into consideration the fact that neural crest cells migrate from the dorsal neural tube 
and with the knowledge that hES cell-derived neural tube-like structures express the dorsal 
markers PAX3 and PAX7, the question came up whether neural crest cells can be found in 
their periphery. During cultivation of plated EBs, it was observed that crescent-shaped aggre-
gates formed in the periphery of plated EBs, which contained the neural tube-like structures in 
Figure 9: Neural tube-
like structures show ex-
pression of dorsal markers 
at the outer edges. RT-PCR 
demonstrates expression of 
PAX3, PAX7, and SHH in 
isolated NTLS (A). Young 
rosettes, appearing at day 3 
after plating of EBs showed 
an overall staining of dorsal-
specific PAX3 and PAX7 
(B+C). In more mature ro-
settes (NTLS, day 6) the 
marker expression was con-
centrated predominantly at 
the outer edges (D+E, in-
sets). In contrast, SHH ex-
pression was found in inner 
side of the lumen (E). The 
lumen of the rosettes is 
marked with asterisks. B-F: 
Nuclei are counterstained 
with DAPI (blue). Scale bars: 
200µm. A: Positive control: 
Human fetal spinal cord. 
NTLS: Neural tube-like struc-
tures. 
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their centers. Those crescent-shaped aggregates (in the following also referred to as delami-
nates) were even macroscopically detectable (Fig. 10A, arrows). Using the low magnification 
of a binocular microscope the self-organization of the plated EB becomes strikingly visible. 
While neural tube-like structures have formed in the centers of the plated EBs, crescent-
shaped aggregates formed in their periphery (Fig. 10B, arrows). The aggregates formed relia-
bly in a distance of 500-600 µm to the center of the plated EBs.  
When examining the plated EB cultures for the expression of SOXE, TFAP2A, HNK-1 and 
p75NTR, it was found that those neural crest associated markers were increasingly expressed 
in the crescent-shaped aggregates. For the detection of SOXE, an antibody was used that rec-
ognizes SOX8, 9 and 10. SOXE transcription factors are important regulators of the neural 
crest. In the crescent-shaped aggregates strong expression of SOXE was detected (Fig. 
10C+D). Another transcription factor associated with neural crest development is TFAP2A 
(also called AP2α). Expression of TFAP2A could also be detected in the delaminates (Fig. 
10C). In addition, cells in the aggregates expressed the carbohydrate epitope HNK-1 (Fig. 
10F) and the low affinity nerve growth factor p75NTR (Fig. 10G), proteins that are expressed 
on the surface of neural crest cells.  
 
Figure 10: Neural crest 
cells migrate from the neural 
tube-like structure contain-
ing area and accumulate to 
aggregates at a distinct dis-
tance to the plated EBs. 
Crescent-shaped aggregates 
were macroscopically visible 
(A) Migrating neural crest cells 
expressed SOXE (C+D), 
TFAP2A (E), HNK-1 (F) and 
p75NTR (G). C, E-G: The cen-
ters of the plated EBs are 
marked with asterisks. Note 
that cells expressing neural 
crest markers accumulated in 
crescent-shaped aggregates in 
the periphery of plated EBs. C-
G: Nuclei were counterstained 
with DAPI (blue). Scale bars: 
C: 500 µm; E-G: 200 µm.  
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To visualize the dynamic process of neural crest cells leaving the plated EB, time-lapse imag-
ing of a plated EB was performed. The plated EB was monitored for 72 hours, subsequently 
fixed and stained for p75NTR (Fig. 11). The resulting video shows that initially after plating, 
cells with a flat, fibroblast-like morphology started to grow out of the EB. In subsequently 
performed immunostainings, those cells were found to be negative for p75NTR. Following 
the flat cells, elongated cells appear at the outer edges of the EB, which were identified by 
post-movie immunostaining as p75NTR-positive, leading to the conclusion that p75NTR-
positive cells start to leave the EB around day 3 after plating. Six days after plating p75NTR-
positive cells were found augmented in the crescent-shaped aggregates in the periphery of the 
plated EBs (Fig 10). The movie can be found in the appendix of this thesis, Fig. 11 shows the 
development of the plated EB in 10-hour-intervals.  
 
Figure 11: Plated EB monitored by time-lapse imaging for 72 hours. Associated illustrations to 
time-lapse video, the plated EB is shown in 10-hour intervals. The last figure shows the subsequent 
p75NTR staining of the fixed EB. Nuclei are counterstained with DAPI (blue). Scale bar: 100µm.  
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3.4 Crescent-shaped aggregates form in the periphery of iso-
lated neural tube-like structures 
In order to elucidate whether neural crest cells continue to migrate also from isolated and re-
plated neural tube-like structures, hES cell-derived neural tube-like structures were isolated 
from 8-day-old plated EB cultures, showing typical self-organization (Fig. 12A), with neural 
tube-like structures in the center of the plated EB and the crescent-shaped aggregates contain-
ing of neural crest cells in the periphery. Neural tube-like structures were isolated using a ster-
ile cannula, replated on PO/Fn/Ln-coated cell culture dishes and cultivated for 4 days in N2 
medium supplemented with FGF2 and Fn. After this additional cultivation time, again neural 
crest cells migrated from the plated neural tube-like structures and formed aggregates in the 
periphery of the plated neural tube-like structures (Fig. 12B). Subsequent staining for 
p75NTR showed that those aggregates were positive for the neural crest marker p75NTR 
(Fig. 12C).  
 
 
 Figure 12: Isolated neural tube-like structures giving rise to p75NTR-positive cells. Neural 
tube-like structures were isolated from 8-days-old plated EB cultures (A), replated on PO/Fn/Ln-
coated cell culture dishes and cultivated for 4 days in the presence of FGF2 and Fn. After 4 days of 
culture, crescent-shaped aggregates formed in the periphery of the isolated rosettes, which stained 
positive for p75NTR (B+C). C: Nuclei were counterstained with DAPI (blue). Scale bar: F: 100 µm. 
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3.5 Switching Cadherin expression patterns in human  
embryonic stem cell-derived neural crest cells mimic in 
vivo Cadherin distribution   
Having identified neural crest cells in the periphery of hES cell-derived neural tube-like struc-
tures, it should be investigated whether this cell culture model can be exploited to study 
events of human neural crest development in vitro.  
As neural crest cells leave the neural tube and start their migration they undergo an epithelial-
to-mesenchymal transition (EMT; Duband et al., 1995). In doing so, they have to go through 
massive cellular changes. These changes are accompanied by alterations in cadherin expres-
sions (Taneyhill, 2008). Cells in the neural plate express E-cadherin, which is switched to  
N-cadherin in the rising neural folds (Hatta et al., 1987; Thiery et al., 1984). N-cadherin aids 
the meeting folds to recognize themselves as tissue of the same kind and therefore facilitates 
their fusion. While the cells in the densely packed epithelial structure of the neural tube ex-
press N-cadherin, delaminating neural crest cells downregulate N-cadherin and express cad-
herin-7 and -11 instead. This type II cadherins prompt neural crest cells to gain a mesenchy-
mal morphology, which they require to start their migration (Nakagawa and Takeichi, 1995; 
Nakagawa and Takeichi, 1998). As neural crest cell migration ceases and the cells cluster to 
form the ganglia, N-cadherin expression is upregulated again (Akitaya and Bronner-Fraser, 
1992; Kasemeier-Kulesa et al., 2006). All this understanding of neural crest development 
comes from studies on several animal models, including mouse, frog and chicken, but so far 
EMT of neural crest cells has not been studied in primates. Here, it was investigated whether 
switches in cadherin expressions can be detected in developing neural crest cultures. There-
fore different compartments of the whole plated EB culture were analyzed. The crescent-
shaped delaminate and the neural tube-like structures were isolated by manual picking and 
compared to the whole plated EB culture at day 3 and 8 by immunoblot analysis (Fig. 13A). 
As a loading control beta-actin expression was assessed. E-cadherin expression was found in 
the whole plated EB culture at day 3 and 8, faintly in isolated neural tube-like structures and 
absent in the isolated crescent-shaped delaminate. N-cadherin was expressed at day 3 and 8 of 
the whole plated EB culture and persisted in the isolated neural tube-like structures, but was 
absent in the isolated delaminate. On the other hand, the isolated delaminate showed strong 
expression of cadherin-7 and -11, which was not expressed in neural tube-like structures and 
was detected to a lesser extend in the whole plated EB cultures. N-cadherin was also visual-
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ized on different stages of the whole plated EB culture using immunocytochemistry. In 8-
days-old plated EB cultures, SOXE expression was detected in cells in the periphery of the 
neural tube-like structures, leaving the neural tube-like structures with N-cadherin expression 
only (Fig. 13B). In spontaneously differentiating neurons, N-cadherin expression was strongly 
expressed in the neurites (Fig. 13C). This is explained by the observed upregulation of N-
cadherin expression during dorsal root and sympathetic ganglia formation. N-cadherin causes 
neural crest cells to cease migration at ganglia sites by mediating adhesive cell-to-cell con-
tacts (Akitaya and Bronner-Fraser, 1992; Kasemeier-Kulesa et al., 2006).  
 
Figure 13: Developing hES cell-derived neural crest cells show a switch in cadherin expres-
sion. Western blot analysis showed expression of E-cadherin in the whole cultures of plated EBs, but 
is just faintly expressed in NTLS and absent in isolated neural crest delaminates. N-cadherin was ex-
pressed in the whole culture of plated EBs and in isolated NTLS, but was absent in the isolated ag-
gregates. Expression of Cadherin-7 and -11 on the other hand was upregulated in the isolated aggre-
gates in comparison to the whole plated EB culture and NTLS (A). Immunocytochemistry of N-
cadherin in whole plated EB culture (d6-7) showed expression of N-cadherin exclusively in the neural 
tube-like structures, namely in the lumen. Migrating SOXE positive cells were negative for N-cadherin 
(B). In differentiating cells, N-cadherin was upregulated again (C). B+C: Nuclei are counterstained with 
DAPI (blue). Scale bars: 100 µm. NTLS: Neural tube-like structures. 
 
Altogether these results indicate that switching cadherin expression can be detected in human 
neural crest cell development in vitro, in a pattern similar to what is observed in vivo in 
various animal models.  
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3.6 Spontaneous differentiation of peripheral neurons in the 
periphery of plated embryoid bodies 
In addition to proliferating undifferentiated neural crest cells, a significant number of mature 
neurons were found in the periphery of the plated EBs. Occasionally, in the periphery of 
plated EBs the formation of ganglion-like clusters was observed, from where the neurites ex-
tended (Fig. 14A+B). Remarkably, those neurons developed in the absence of any neuronal 
supporting factors except for FGF2 and Fn and appeared in the cultures already six days after 
plating of the EBs.  
The neurons exhibited long axons, showed strong expression of Peripherin and co-expressed 
BRN3A (Fig. 14C+D). The typical long axons, as well as the double staining of Peripherin 
and BRN3A is a strong indication for peripheral neurons of a sensory phenotype. 
 
 
3.7 Isolation of neural crest cells by manual picking 
As a next step, a highly purified population of proliferating, undifferentiated neural crest cells 
should be established. The distinct crescent-shaped aggregates in which the neural crest cells 
assembled could easily be detected with the binocular microscope and therewith allowed for 
an efficient morphology-based isolation (Fig. 15A). The characteristic aggregates were circled 
with a sterile cannula and transferred into medium filled, Fn-coated cell culture dishes, where 
they could readily be replated. Upon replating of the isolated crescent-shaped aggregates cells 
Figure 14: Sensory 
neurons are found during 
early differentiation. Pe-
ripherin-positive neurons 
emerged in the periphery of 
neural rosettes (A+B). Pe-
ripherin-positive neurons 
exhibited bipolar morphol-
ogy with long axons and co-
expressed BRN3A (C+D). 
Nuclei are counter-stained 
with DAPI (blue). Scale 
bars: B: 500 µm, C: 200µm, 
D: 100µm  
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Figure 15: hES cell-derived NC cells can be isolated manually as they form evidently rec-
ognizable aggregates. Crescent-shaped aggregates can be manually isolated by picking with a 
sterile canula (A). Upon replating of aggregates, cells migrate out of the clusters over the fi-
bronectin-coated dish. Those cells expressed p75NTR (B), as well as SOXE (C). Scale bars: 200 
µm. 
 
 
migrated from them. The cells exhibited a bipolar, spindle-shaped morphology. So as to 
clarify the cellular identity of the migrating cells, immunocytochemical analysis was per-
formed. The expression of neural crest specific markers was assessed. The cells, as well as the 
cells residing in the cluster expressed the neural crest-associated markers p75NTR, AP2α, as 
well as SOXE (Fig. 15B-D). 
 
 
 
 
In order to investigate the behavior of the cells within the isolated aggregates, time-lapse im-
aging of isolated aggregates was performed. Upon plating of the aggregate, the strong migrat-
ing behavior of the cells could be observed. Cells were monitored for 72 hours. Already after 
10 hours the first cells started migrating. Migrating cells populated approximately half of the 
lens coverage after 20 to 30 hours. The bipolar, spindle-shaped cells migrating out of the 
plated aggregates covered up to 90% of the field of view after 50 to 60 hours. Complete con-
fluence of the cell culture dish was achieved after 70 hours. The movie can be found in the 
appendix of this thesis. Figure 16 shows the migrating cells in 10 hour-intervals. After light 
microscopy analysis the cells were analyzed for neural crest specific key molecule expression, 
e.g. p75NTR and others in order to confirm initial findings (see Fig. 15). Cells that migrated 
out of the plated aggregates readily stained positive for neural crest specific markers (data not 
shown). 
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Western blot analysis confirmed the strong enrichment of neural crest cells upon this simple 
manual enrichment procedure. Using p75NTR- and SOX10-specific antibodies, different 
compartments of the plated EB culture were analyzed. For this purpose, delaminates and neu-
ral tube-like structures were isolated separately by manual picking and as control, protein 
lysate from the initial heterogeneous population of the whole plated EB culture, was used. 
The expression of beta actin was analyzed in order to function as loading control. The isolated 
delaminate clearly showed an elevated level in the expression of p75NTR and SOX10 protein 
(Fig. 17A).  
To further characterize the isolated delaminate, RT-PCR was performed to analyze the ex-
pression of more neural crest-associated genes (Fig. 17B). The expression of the transcripts 
NGFR, SOX10, B3GAT1 (HNK-1), SNAI2, SNAI1 and TFAP2A (AP2α) was elevated, further 
underlining the results of immunocytochemical analysis shown above. 
Figure 16: Time-lapse im-
aging of a replated isolated 
delaminate. Pictures show cell 
outgrowth in 10 hour-intervals. 
Over 70 hours the cells display 
excessive migration. Charac-
teristic immunocytochemical 
analyses are shown in Fig. 15. 
Scale bar: 100µm.  
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Figure 17: Analysis of manually isolated aggregates. The neural crest identity was also 
confirmed by immunoblot analysis, here a SOX10 specific antibody was used. In comparison with 
isolated neural tube-like structures, cells in the isolated delaminate upregulated p75NTR as well as 
SOX10 (A). The isolated cell population was tested for several neural crest-associated markers via 
RT-PCR. Expression of NGFR and SOX10 was confirmed; additionally expression of B3GAT1 (HNK-
1), SNAI1, SNAI2 and TFAP2A was detected (B). B: Positive control: Human Schwannoma biopsy.  
 
Upon enzymatic detachment and trituation a homogenous cell population was obtained that 
efficiently plated on Fn-coated cell culture dishes. The population displayed p75NTR expres-
sion at a purity of 95.3±3.6% (Fig. 18A). Virtually all p75NTR-positive cells co-expressed 
SOXE (Fig. 18B). The cell population proliferated in the presence of growth factors FGF2 
and EGF and could be passaged every three days at a 1:3 ratio. For differentiation paradigms 
cells not older than passage 3 were used, as with increasing passage number the cell prolifera-
tion, as well as the capacity for neuronal differentiation, declined (data not shown). 
 
 
 
Figure 18: Trituation of manually isolated crescent-shaped aggregates led to a homogenous 
cell population. Upon trituation of clusters a homogenous cell population was yielded, expressing 
p75NTR (A), as well as SOXE (B). Nuclei counterstained with DAPI. Scale bars: 200 µm. 
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In order to demonstrate the efficiency of the manual isolation procedure, the result was com-
pared with a purified population obtained by FACSorting for p75NTR expression. For that 
purpose plated EB cultures were enzymatically detached from the dish, singularized and sub-
jected to live immunostaining for p75NTR. Cell sorting was performed in cooperation with 
the Flow Cytometry Core Facility situated at the Institute of Molecular Medicine, Medical 
Center, University of Bonn. 
The p75NTR positive population was evidently distinguishable from negative cells, and made 
up 15.2±5.2 % of the whole culture (Fig. 19A). The sorted cells could be expanded to form a 
homogenous monolayer expressing p75NTR (Fig. 19B). Virtually all cells showed expression 
of SOXE (Fig. 20C). Sorted cells expressed p75NTR at a purity of 94.2±2.2%, resembling the 
purity that was achieved by manual picking (95.3±3.6%; Fig. 19D).  
 
 
Manual picking offers an attractive alternative to FACSorting due to various reasons. It 
causes less stress to the cells, is also less susceptive to contamination and a fast method of 
isolation. Furthermore, the yield of positive cells is considerably higher. In addition, as no 
antibody staining and expensive equipment are needed it is cheaper compared to FACSorting. 
As for these reasons, all further experiments aiming at the further characterization and differ-
Figure 19: Isolation of neural crest cells 
from whole plated EB cultures by FACS. 
P75NTR-positive cells were readily distinguish-
able from other cell types (A) and made up 
15.2±5.2 % of the whole plated EB culture (here a 
representative histogram is shown). Isolated cells 
were plated in low densities and proliferated in 
culture to form a confluent homogenous cell layer 
within seven days, expressing p75NTR (B) and 
SOXE (C). Cells expressed p75NTR with a purity 
of 94.2±2.2%, comparable to the purity of manu-
ally isolated cells (95.3±3.6%; D). B+C: Nuclei 
counterstained with DAPI (blue). Scale bars: 200 
µm.  
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entiation of human ES cell-derived neural crest cells were carried out on manually isolated 
cell populations. 
 
3.8 Microarray analysis shows substantial gene expression 
differences between neural crest cells and a human  
embryonic stem cell-derived neural stem cell population 
Considering ease and efficiency of the manual isolation technique, delaminate-derived cells 
were used for all further studies. To further characterize the isolated cell population, a mi-
croarray analysis using Illumina array technology was performed in collaboration with Dr. 
Michael Alexander (Department of Genomics, Life&Brain Center, University of Bonn). Here, 
a long term-proliferating, rosette-type neural stem cell population (lt-hESNSCs), which was 
initially obtained from hES cell-derived neural tube-like structures established from the same 
parental hES cell line was used as comparison (Koch et al., 2009).  
 
 
 
 
Figure 20: Comparison of isolated delaminates vs. lt-hESNSCs by microarray analysis. 
The figure represents the gene expression levels of several top marker genes from lt-hESNSCs 
and isolated delaminates assessed by microarray analyses (Illumina human HT-12 Expression 
BeadChips v3). Fluorescence intensity of marker genes from duplicate analyses was average 
normalized and compared (lt-hESNSCs versus isolated delaminates and isolated delaminates 
versus lt-hESNSCs) to create a fold-change of gene expression levels. Expressed genes with high 
expression levels in isolated delaminates compared to lt-hESNSCs are shown in blue and ex-
pressed genes with high expression levels in lt-hESNSCs compared to isolated delaminates are 
shown in red. 
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The differential expression of a selected neural crest and neural stem cell marker set was in-
vestigated. Fold change differences were found for the neural crest-associated markers: 
MSX1, TFAP2A (AP2α), TWIST1, S100A10, SOX9, TFAP2B (AP2β), CDH11 (cadherin-11), 
SNAI2, ERBB3, EDNRA, S100A11, SOX10, POU4F1 (BRN3A), NGFR (p75NTR) and SNAI1, 
showing an upregulation of these genes in the isolated delaminates. In contrast, typical neural 
rosette markers such as FABP7, POU3F2, SOX3, SOX2, PROM1, MMRN1, ASCL1, PAX6, 
HES5, PLAGL1 were found downregulated in the delaminate-derived cells (Fig. 20) com-
pared to hESC-derived neural stem cells. 
 
3.9 Isolated neural crest cells can readily be differentiated 
into different types of peripheral neurons 
Neural crest cells give rise to sensory neurons of the cranial nerves and the dorsal root ganglia 
and autonomic neurons of the sympathetic and enteric ganglia. In order to assess the neuronal 
differentiation potential of the isolated hES cell-derived neural crest cells, cells were culti-
vated in neuronal differentiation medium supplemented with the neurotrophins BDNF and 
NGF. Both are known to support the survival and differentiation of sensory neuron precur-
sors; BDNF by binding to the receptors TrkB and p75NTR, and NGF by binding to TrkA and 
p75NTR (Patapoutian and Reichardt, 2001).  
 
Figure 21: hES cell-
derived neural crest 
cells differentiate into 
different types of pe-
ripheral neurons. Dif-
ferentiation in neuronal 
medium containing NGF 
and BDNF yielded 
21.7±5.1% of Pe-
ripherin/BRN3a positive 
neurons, which are con-
sidered as sensory neu-
rons due to the expres-
sion of this marker 
combination  (A+B, D). 
Furthermore 6.3±1.3% 
of Peripherin/TH posi-
tive cells are obtained, 
which are considered as 
autonomic neurons 
(C+D). Scale bars: A: 
200 µm, B, C: 100 µm. 
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During the differentiation paradigm the formation of ganglion-like neuronal clusters could be 
observed (Fig. 21A-C). Double labeling with antibodies to Peripherin and BRN3A, a marker 
combination typically used to identify sensory neurons (Fedtsova and Turner, 1995), revealed 
21.7±5.1% immunopositive cells (Fig. 21A+B, D). Peripherin and TH, a marker combination 
indicating autonomic lineages (Mizuseki et al., 2003) was found in 6.3±1.3% of the cells (Fig. 
21C+D).  
In order to characterize the neuronal population, a more detailed RT-PCR analysis of prolifer-
ating neural crest cells and neuronal differentiated cells thereof were performed (Fig. 22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
RT-PCR further confirmed the expression of PRPH (Peripherin), POU4F1 (BRN3A), and TH, 
which have also been assessed by immunocytochemical analysis. While for PRPH and 
POU4F1 an upregulation could be observed after differentiation, TH was also strongly ex-
pressed in proliferating cells. This observation is compatible with data of Young et al. 
suggesting that some undifferentiated neural crest precursors show a transient expression of 
this hydroxylase (Young et al., 1999). In addition, expression of SOX10, which is transiently 
expressed in sensory neurons (Carney et al., 2006) and the neuronal marker PAX3 (Koblar et 
al., 1999) was detected. Not surprisingly, those markers were also expressed in proliferating 
Figure 22: RT-PCR profile of neuronal differentiated iso-
lated neural crest cells. RT-PCR confirmed expression of 
PRPH (PERIPHERIN), POU4F1 (BRN3A) and TH, which also 
have been assessed by immunocytochemical analysis. Addi-
tionally expression of SOX10 and PAX3 but also ASCL1, 
PHOX2B, and NTRK1 (TrkA), NTRK2 (TrkB), and NTRK3 
(TrkC) was revealed. No expression of the central motoneuron 
marker MNX1 was detected (E) Positive controls: POU4F1, 
SOX10, PAX3, ASCL1, NTRK1, NTRK2, NTRK3, TH, MNX1: 
Human fetal spinal cord; PRPH, PHOX2B: Human fetal colon 
tissue. GAPDH is representatively shown for human fetal spinal 
cord. hNCCs: Human neural crest cells. 
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neural crest cells. Furthermore the expression of markers indicative for peripheral neuronal 
subtypes, for which no antibodies were available, was investigated. The expression of NTRK1 
(TrkA), expressed by peptidergic small diameter neurons mediating pain sensation, and 
NTRK2 and -3 (TrkB and TrkC), which is found in large diameter mechanoreceptive and pro-
prioceptive neurons (Mu et al., 1993; Wright and Snider, 1995) was detected. Moreover the 
expression of ASCL1 and PHOX2B was identified, genes, which play an essential role in the 
development of the sympathetic, parasympathetic, and enteric ganglia within the peripheral 
autonomic nervous system (Pattyn et al., 1999). On the other hand, MNX1 (HB9), a marker 
for CNS motoneurons (Vult von Steyern et al., 1999), could not be detected in the differenti-
ated cells.  
In order to verify the functionality of the obtained neurons, their electrophysiological proper-
ties were assessed. All electrophysiological measurements were performed in collaboration 
with Dr. Jaideep Kesavan (Institute of Reconstructive Neurobiology, Medical Center, Univer-
sity of Bonn). For long-time differentiation, isolated neural crest cells were plated on mitoti-
cally inactivated astrocytes and cultivated in neuronal differentiation medium for 6-8 weeks.  
Current-clamp measurements were performed to elicit action potentials. All of the neurons 
tested generated multiple action potentials during current injection (Fig. 23A). Voltage-
dependent membrane currents were also observed in these neurons (Fig. 23B). The fast and 
transient inward current was sensitive to the application of 300 nM TTx (a selective Na+ 
channel blocker). One of the hallmarks of neurons is their ability to form synapses. Therefore, 
whole-cell voltage-clamp recordings were performed in these neurons to monitor spontaneous 
synaptic currents. Spontaneous postsynaptic currents were observed in whole-cell voltage-
clamp recordings indicating functional synapses in these neurons (Fig. 23D). Thus, neurons 
derived from neural crest cells exhibited functional characteristics in vitro. After patch-clamp 
recordings, post-hoc immunostaining of the recorded neurons revealed co-localization of bio-
cytin (diffused from the patch pipette to the cell) and peripherin (Fig. 23E). However, occa-
sionally neurons detached from the culture dish after patch-clamp measurements, thus making 
post-hoc immunostainings impossible. No obvious differences in the electrophysiological 
properties of any of the neurons measured could be observed. 
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Figure 23: Electrophysiological analysis of the neural crest cell-derived neuronal popula-
tion. Neural crest-derived neurons fired action potentials in response to step depolarization by current 
injection (A). Depolarizing voltage steps elicited voltage-dependent fast inactivating inward and sus-
tained outward currents. The fast inward currents were blocked by bath application of 300 nM TTx (B). 
The boxed region in B is shown at a higher magnification (C). Representative traces of spontaneous 
synaptic currents from neural crest-derived neurons (D). Post-hoc staining of the recorded cells re-
veals co-localization of Peripherin and biocytin (diffused from the path pipette into the recorded cell) 
(E). Scale bars: 100 µm. 
 
3.10 Isolated neural crest cells give rise to putative Schwann 
cells 
In vivo, Schwann cells need the contact to neurons to proliferate and differentiate. In vitro, 
these environmental cues can be mimicked by the application of certain factors. In order to 
differentiate isolated neural crest cells into Schwann cells, a powerful glial instructor, NRG-1, 
was used. NRG-1 is secreted from peripheral neurons and plays the central role in Schwann 
cell growth and differentiation. It also regulates the thickness of myelin (Michailov et al., 
2004). Isolated hES cell-derived neural crest cells were initially cultivated in the additional 
presence of FGF2, as it is known to promote Schwann cell proliferation after nerve injury 
(Jungnickel et al., 2006). In addition, cell culture medium was supplemented with Forskolin, 
which increases the intracellular level of cAMP. This in turn, enhances the NRG-dependent 
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proliferation of Schwann cells and also promotes the maturation and myelination of Schwann 
cells (Sobue et al., 1986). 
After three weeks of proliferation in Schwann cell supporting medium, FGF2 was withdrawn 
from the medium to initiate terminal differentiation. Upon differentiation the cells showed a 
spindle-like morphology, typical for Schwann cells. 40.4±17.4% expressed the marker com-
bination p75NTR/L1CAM, 30.1±16.0% expressed p75NTR/GFAP (Fig. 24A+B). The ex-
pression of markers associated with mature Schwann cells was analyzed by RT-PCR (Fig. 
24C). In addition to NGFR (p75NTR), L1CAM and GFAP, expression of SOX10, CNP and 
EGR2 (Krox20) was detected. L1CAM, SOX10 and p75NTR are expressed in proliferating 
neural crest cells, as well as in differentiated cultures. SOX10 and p75NTR are, as described 
above, markers for undifferentiated neural crest cells and persist during glial differentiation. 
L1CAM has also been shown in proliferating neural crest cells. Surprisingly, proliferating 
cells also show a high level of CNP, a marker for Schwann cells and Oligodendrocytes. This 
is compatible with data by Chandross and colleagues, who showed that the CNP promoter is 
active in neural crest progenitors, i.e. specifies early Schwann cell precursors (Chandross et 
al., 1999). In the case of GFAP and EGR2 an upregulation in the differentiated cultures could 
be observed. 
 
 
 
 
 
 
 
Figure 24: hES cell-derived NC cells differentiate into Schwann-like cells. Upon cultivation 
in FGF, Forskolin and NRG-1 followed by terminal differentiation induced by FGF2 withdrawal, 
40.4±17.4% of cells expressed L1CAM/p75NTR (A) and 30.1±16.0% p75NTR/GFAP (B) were 
obtained. Positive cells adopted a spindle-like morphology. RT-PCR additionally confirmed ex-
pression of mature Schwann cell markers, namely GFAP, L1CAM, SOX10, NGFR (p75NTR), 
EGR2 (Krox20), and CNP (C). A+B: Nuclei were counterstained with DAPI. Scale bars: 100 µm. 
C: Positive control: Human Schwannoma biopsy.  
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3.11 Isolated neural crest cells give rise to mesenchymal  
derivatives 
 Neural crest cells are able to differentiate into several mesenchymal cell types, including 
smooth muscle cells, bone and cartilage of the head, as well as adipocytes. Neural crest-
derived smooth muscle cells are found in the heart and in the gastrointestinal tract. In order to 
induce differentiation of the isolated human neural crest cell population into mesenchymal 
cell types, they were cultivated in the presence of 10% FCS, culture conditions known to 
promote mesenchymal differentiation. The cultivation in DMEM+10% FCS for three weeks 
yielded 82.7±3.3% SMA-positive cells (Fig. 25A). RT-PCR revealed in addition to ACTA2 
(SMAα) an upregulation of ACTG2 (SMAγ) gene expression, an actin isoform present in en-
teric smooth muscle cells (Fig. 25B). 
 
Figure 25: hES cell-derived NC cells differentiate into smooth muscle cells. Treatment of iso-
lated NC cells with FCS led to formation of 82.7±3.3% SMA positive cells (A). RT-PCR revealed be-
neath the expression of ACTA2 (SMAα) as well as the expression of ACTG2 (SMAγ), which is found in 
enteric smooth muscle cells (B). A: Nuclei were counterstained with DAPI. Scale bar: 100 µm. B: Posi-
tive control: Human fetal colon. 
 
In order to facilitate the differentiation and survival of chondrocytes, ascorbic acid, forskolin 
and FGF2 were added to the mesenchymal basic medium, as these factors are known to have 
a promoting effect on chondrogenic differentiation (Ido and Ito, 2006; Sarkar et al., 2001). 
After 4 weeks in this medium, clusters of chondrocytes that stained positive for alcian blue 
were detected (Fig. 26A+B). Alcian blue stains accumulations of mucopolysaccharides asso-
ciated with chondrocyte differentiation (Schofield et al., 1975). Additionally, the clusters ex-
pressed S100β (Fig. 26C), which is associated with chondrogenesis as well (Stefansson et al., 
1982; Vega et al., 1990). 
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Figure 26: hES cell-derived neural crest cells differentiate into chondrocyte nodules. Upon 
differentiation of isolated neural crest cells in high density in chondrocyte promoting medium, chondro-
cyte nodules formed, which stained positive for Alcian Blue (A+B), as well as S100β (C). Scale bar: C: 
100 µm. 
 
To explore the potential of hES cell-derived neural crest cells for adipocyte differentiation, 
cells were cultivated in the presence of hydrocortisone, isobutylmethylxanthine and indo-
methacine, which are reagents used for the promotion of adipocyte differentiation (Fang et al., 
2005; Hauner et al., 1989). Upon three weeks of differentiation, numerous cells developed 
intracytoplasmic lipid droplets positive for oil red staining (Fig. 27A). This is a typical stain-
ing pattern used to identify adipocytes. (Ramirez-Zacarias et al., 1992).  
For osteoblast differentiaton, cells were cultured 3 weeks in the presence of Dexamethasone, 
L-ascorbic acid and β-glycerolphosphate (Fang et al., 2005; Jaiswal et al., 1997). Identifica-
tion of osteoblasts was done by Alizarin red staining (Fig. 27B), which visualizes calcium-
rich deposits (Bodine et al., 1997).  
Pronounced variability in the formation of lipid droplets within adipocytes and cluster forma-
tion of chondrocytes and osteoblasts precluded a precise quantification of these cell types. 
 
Figure 27: hES cell-derived neural crest cells readily differentiate into adipocytes and os-
teoblasts. Upon cultivation of isolated neural crest cells in appropriate conditions, adipocytes, identi-
fied by the inclusion of lipid droplets stained by oil red (A), as well as osteoblasts, identified by the 
staining of calcium rich areas by alizarin red (B), were obtained.  
  
  
 
Results 
 
66 
 
Mesenchymal derivatives are mainly derived from cranial neural crest cells. As the isolated 
hES cell-derived neural crest population readily differentiated into the mesenchymal deriva-
tives, their expression of transcription factors associated with neural crest cells from the head 
region was investigated by RT-PCR (Fig. 28).  
The HOX genes of the second homologue were found highly expressed in the isolated popula-
tion, namely HOXA2 and HOXB2. Expression of those genes was shown in the migrating 
streams of cranial neural crest (Hunt et al., 1991). Furthermore, cells showed expression of 
GBX2 and OTX2, which are involved in the formation and pattering of the head. GBX2 was 
shown to be expressed in migrating cranial neural crest cells and the pharyngeal arches 
(Kikuta et al., 2003). OTX2 expression has also been observed in cranial neural crest cells 
(Kimura et al., 1997). 
 
 
 
 
 
 
 
 
 
FOXG1, expressed in the ventral telencephalon and placode cells (Duggan et al., 2008; Pratt 
et al., 2002), was not detected in the isolated cells. The same is true for NKX2-2, likewise as-
sociated with ventral organization (Briscoe et al., 1999). As a positive control, cDNA of hu-
man fetal brain was used in the RT-PCR. The expression of the housekeeping gene GAPDH 
was assessed in order to be able to compare the expression of the hES cell-derived neural 
crest population with the positive control. 
 
 
Figure 28: Isolated neural crest cells express markers 
associated with cranial neural crest cells. Isolated neural 
crest cells show high expression of HOXA2 and HOXB2, as 
well as GBX2 and OTX2, which are associated with migrating 
cranial neural crest cells. In contrast, they do not show expres-
sion of FOXG1 or NKX2-2, connected to ventral organization of 
the head. Positive control: Human fetal brain. 
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4 Discussion 
The hES cell-based model system presented here allows for the recapitulation of neural crest 
development in vitro.  Remarkably, it could be observed that differentiating hES cells mimic 
early neurulation and patterning events occurring in vivo. Mature neural rosettes display a 
dorsal-ventral marker expression pattern, further strengthening the idea of a neural tube-like 
character. Neural crest cells emerge in parallel to neural tube-like structures, delaminate and 
re-aggregate in their periphery. This dynamic process not only provides experimental access 
to the early events of human neural crest formation including migration cues but also facili-
tates the in vitro generation of various neural crest cell types, which can be directly differenti-
ated from isolated delaminated aggregates. In the following the two key aspects of the hES 
cell-based model system, the recapitulation of neural crest development in vitro and the me-
thodical benefits in terms of efficiency of the protocol and differentiation potential of hES 
cell-derived neural crest cells, will be elaborated. 
 
4.1 Neural crest development can be recapitulated in vitro 
HES cell-derived neural tube-like structures acquire a dorsal-ventral organization  
HES cell-derived neural rosettes have previously been shown to exhibit characteristics similar 
to the developing neural tube, as they exhibit a primitive dorsal-ventral patterning (Li et al., 
2005). However, as cultivation occurs in an artificial 2D cell culture model, neural rosettes 
lack the organization present in vivo. During embryonic development neuroepithelial cells 
face the basal lamina at their basal side, and the amniotic fluid at their apical side. As the neu-
ral plate forms the neural tube, the apical side faces the lumen of the neural tube. This apical-
basal orientation of the cells is also observed in hES cell-derived neural rosettes. In the pre-
sented study the expression of dorsal transcription factors PAX3 and PAX7 was found con-
centrated and elevated at the outer edges of hES cell-derived neural rosettes, while the ventral 
marker SHH was detected in the lumen, suggesting a dorsal-ventral patterning of the mature 
neural rosettes. This data add up to the previous published work regarding similarity of ma-
ture neural rosettes to the embryonic neural tube (Colleoni et al., 2010; Elkabetz et al., 2008; 
Li et al., 2005). It was shown in this thesis that early neural rosettes (day 3 after plating of 
EBs) display a diffuse staining of the ventral markers PAX3 and PAX7. These results suggest 
that neural rosettes acquire a dorsal-ventral patterning during prolonged time in culture. 
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Therefore, in the thesis presented here, mature neural rosettes have been termed neural tube-
like structures. 
 
Neural crest cells migrate from neural tube-like structures 
When setting out to discover neural crest cells in differentiating hES cells, one obviously will 
explore the periphery of neural tube-like structures. Thereby it was found that plated EB cul-
tures show a remarkable self-organization. During their cultivation, neural tube-like structures 
arise in their centers. In the periphery, a homogenous cell population builds clusters that are 
arranged in a centrifugal manner around the centered neural tube-like structures. The exten-
sive characterization of the isolated clusters identified this early arising population as neural 
crest cells. So where does the neural crest population come from?  
One theory is that the neural crest cells delaminate from the developing neural tube-like struc-
tures. The neural tube-like organization and the expression of dorsal-ventral markers point at 
this direction. Furthermore, in chapter 3.4 of this thesis it was shown that isolated, separately 
plated neural tube-like structures (from 8-day-old plated EB cultures) gave rise for a second 
time to neural crest cells. Those neural tube-like structures have been isolated from plated EB 
cultures at a time point when neural crest cells already left the neural rosette zone and cres-
cent-shaped aggregates again formed around them. In order to study their migration from 
neural tube-like structures, neural crest cells were investigated for expression of several cad-
herins. The observed expression patterns correspond to the published data of cadherin-
switching, as shown in several animal models during the emergence of neural crest cells from 
the neural tube; i.e. early expression of E- and N-cadherin, downregulation of these cadherins 
in migrating neural crest cells and upregulation of cadherin-7 and -11 instead (Duband et al., 
1995; Taneyhill, 2008). So far, switching in cadherin expression during neural crest develop-
ment has only been identified in animal models. Cadherin-7 has been identified in migrating 
neural crest cells of the chicken and in a subpopulation of migrating neural crest cells in the 
rat (Dufour et al., 1999; Nakagawa and Takeichi, 1998; Takahashi and Osumi, 2008). Cad-
herin-11 has been identified as crucial adhesion molecule in migrating neural crest cells in 
Xenopus and in cranial neural crest cells with mesenchymal differentiation potential in the 
mouse (Borchers et al., 2001; Kimura et al., 1995). Furthermore, Cadherin-11 has been used 
to isolate hES cell-derived cranial neural crest cells (Zhou and Snead, 2008). This is the first 
study to describe the sequential expression of cadherins in human cells.  
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The other hypothesis is that neural crest cells develop in parallel to neural tube-like structures 
instead of actually delaminating from them and reside in-between them before they start to 
proliferate and migrate. This hypothesis is underlined by findings made by Basch and col-
leagues (2006). In this study it was found that the neural crest is induced independently from 
neural tissue and that the medial epiblast is sufficient for neural crest specification. The 
authors conclude that neural crest induction occurs just before or at the time of gastrulation 
and that other observations may be due to cell culture artifacts. The controversial discussions 
in the literature show that neural crest development is still largely unknown; especially onto 
the human system little light has been shed. 
It is striking that in the hES cell-based model appearance and migration of neural crest cells 
occurred without specific external stimulation by BMPs, which have been shown to stimulate 
delamination of neural crest cells from explanted neural tubes (Sela-Donenfeld and Kalcheim, 
2002) or members of the Wnt family, which play a key role in neural crest induction. A study 
by ten Berge and colleagues showed that EBs undergo a process similar to gastrulation and 
even form a primitive streak-like region depending on the activation of the Wnt pathway. Wnt 
signaling is activated spontaneously in the EBs, which is possibly due to the growth factor 
cocktail applied through the cultivation in the presence of serum or serum replacement (ten 
Berge et al., 2008). This shows that EBs possess the capability of self-organization and this 
may also explain the formation of neural tube-like structures, as well as the emergence of neu-
ral crest cells. In the cell culture system presented here, EBs are cultivated in the presence of 
serum replacement, before they are plated and transferred into N2-based medium containing 
FGF2 and fibronectin only. FGFs are, besides BMPs and Wnts, also involved in the induction 
of the neural crest (Monsoro-Burq et al., 2003). FGF2, in combination with BMP2, has been 
shown to be required for the conversion of CNS precursor cells towards neural crest cells 
(Sailer et al., 2005). The supplemented FGF2 might stimulate the neural crest cells to leave 
the neural rosette zone: It is known to promote the proliferation of neural crest cells, so that 
the excessive proliferation and migration of the hES cell-derived neural crest cells may be 
directly linked to the presence of FGF2 in the medium (Kalcheim, 1989; Murphy et al., 1994). 
Fibronectin on the other hand is known to promote neural crest adhesion and migration via 
integrins in an indirect manner (Strachan and Condic, 2008).  
Another factor that might play a role in neural crest migration from the neural rosette zone are 
the flat, fibroblast-like cells that were observed in the time lapse imaging of the plated EB. 
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These cells leave the EB first, before the p75NTR-positive cells appear at the border. Possibly 
they are secreting chemokines that attract newborn neural crest cells to migrate. Moreover, the 
neural tube-like structures may provide cues that cause neural crest cells to delaminate and 
migrate, as also suggested in other publications (Lazzari et al., 2006; Colleoni et al., 2010). In 
future experiments it will be of great interest to investigate whether the presence of neural 
tube-like structures causes activation of signaling pathways in the neural crest cells. Possibly, 
the amount of neural crest cells migrating from neural tube-like structures could be enhanced 
by additional external stimuli such as the application of BMPs or members of the Wnt family.   
Another interesting aspect of the segregation phenomenon of the plated EB culture is, beside 
the origin and migration of neural crest cells, the cease of cell migration, which leads to for-
mation of the characteristic cell aggregates. At a defined distance from the neural tube-like 
structures neural crest cells stop to migrate and aggregate to form crescent-shaped clusters. 
The crescent-like shape is possible due to the centrifugal migration of neural crest cells from 
the plated EB. From these clusters cells sporadically continue to migrate. As the clusters were 
isolated, cells extensively grew out of these clusters, as analyzed by time-lapse imaging. The 
heterogeneous culture with the centered neural tube-like structures and the circumjacent cres-
cent-shaped aggregates seems to exhibit a sophisticated balance, which is de-restricted as the 
clusters are isolated and re-plated. During neural crest migration in vivo, some cells also stop 
along the way to start differentiation while others continue migration to other destinations as 
seen with dorsal root ganglia and sympathetic ganglia generation (Duband, 2006; Marmigere 
and Ernfors, 2007). Possibly, the observed pattern of migration points at a mixed pool of al-
ready restricted neural crest precursor cells instead of a homogenous neural crest stem cell 
population. Although isolated neural crest cell populations seem to exhibit multipotency, 
meaning a true neural crest stem cell character, they may still be pre-specified, as it has been 
shown that trunk neural crest cells are able to adapt a cranial cell fate when they are exposed 
to appropriate culture conditions (McGonnell and Graham, 2002). The topic of neural crest 
plasticity is discussed below.  
Future studies may use this interesting model to investigate the cues and signaling pathways 
that are involved in neural crest migration and what causes some cells to stop and others to 
continue migration. The signals from the centered neural tube-like structures may range to a 
certain distance and thereby build a gradient, which may lead to cell aggregation as signals 
decrease. Another possibility is that not the distance from the cells to the neural tube-like 
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structures is determining the cease of migration, but time. The signals from the neural tube-
like structures might change during their further maturation. During normal development, 
timing of neural crest emigration from the neural tube is crucial to determine migration path-
ways and later terminal differentiation. Also, if the described flat fibroblast-like cells, which 
leave the plated EB at first, are causing newborn neural crest cells to migrate, they may stop 
the release of chemokines or even undergo apoptosis, as the culture conditions are not appro-
priate for their maintenance. Another reason may be the substrate used. In vivo, neural crest 
cells are guided into the pharyngeal arches or along the somites. Here, the neural crest cells 
migrate on fibronectin-coated cell culture dishes and this artificial environment may cause 
specific behavior of the adherent cells. Transplantation into the chicken at different develop-
mental stages would be meaningful in order to investigate the migration pathways of the neu-
ral crest cells. 
 
Peripheral neurons emerge early in human embryonic stem cell differentiation 
It is striking that large numbers of cells in the aggregated delaminates already adopted a sen-
sory neuron fate at the plated EB stage. This shows that some cells in the aggregates are al-
ready restricted in their developmental fate. It has been shown from studies in the mouse that 
the presence of the neural tube is essential for the differentiation of the dorsal root ganglion 
(Kalcheim and Le Douarin, 1986). The presence of the neural tube-like structures in the 
plated EB cultures could have a similar effect on the delaminated neural crest cells. This is 
most likely, as usually the differentiation of neural crest cells into sensory neurons requires 
the application of a growth factor cocktail. As sensory neurogenesis in vivo is conducted in 
three waves (for review see Marmigere and Ernfors, 2007), with the first wave differentiating 
predominantly into large mechanoreceptive and proprioceptive sensory neurons, the second 
wave leading to differentiation in all subtypes of sensory neurons and the third wave causing 
differentiation into small neurons, it will be interesting to investigate whether these early 
emerging sensory neurons represent the large mechanoreceptive and proprioceptive sensory 
neurons of the first developmental wave. 
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4.2 The human embryonic stem cell-based model as source 
for multipotent neural crest cells 
Derivation of human embryonic stem cell-derived neural crest cells is fast and efficient 
The research on human neural crest cells is still in the fledging stages but of high significance, 
considering the number of diseases related with neural crest malformation. In recent studies, 
hES cells have been discovered as potential source for neural crest cells and their progeny. 
The published protocols differ in the manner of neural crest induction, length of the culture 
periods, method of isolation of neural crest cells, and differentiation paradigms as well as ob-
tained neural crest phenotypes. Several protocols use co-cultivation with stromal cells for neu-
ral induction (Lee et al., 2007; Pomp et al., 2005). Hotta and colleagues used a combination of 
co-cultivation with feeder or stromal cells and treatment with the small-molecule ROCK1/2 
inhibitor Y27632 (Hotta et al., 2009). However, stromal cells are ill-defined, and co-
cultivations are difficult to standardize. Chambers and colleagues detected an interesting 
population of early neural crest cells in neural rosette cultures derived by treatment with two 
inhibitors of the SMAD signaling pathway. Future studies will have to show the potential of 
this cell population and the differences compared to other hES cell-derived neural crest cells 
(Chambers et al., 2009). Another group isolated Cadherin-11-positive putative cranial neural 
crest cells from embryoid bodies and focused on the osteogenic potential of the cells (Jiang et 
al., 2009). Also, the generation of neural crest cells from hES cell-derived neural spheres has 
been shown (Curchoe et al., 2010). The most recent published study shows that the activation 
of Wnt signaling and suppression of the ActivinA/Nodal pathway led to direct differentiation 
from pluripotent stem cells to neural crest cells (Menendez et al., 2011).  Each protocol for 
itself provides different interesting aspects for the research on hES cell-derived neural crest 
cells, however, they all face some drawbacks and many aspects regarding human neural crest 
development further remain unknown.  
The here presented cell culture model offers a different perspective on neural crest develop-
ment and presents some major advantages upon other in vitro settings. Additionally to the 
above-described capture of early neural crest development, it also offers practical benefits 
according to time, efficiency and span of applications. The segregation and aggregation of 
newly generated immature neural crest cells is exploited to efficiently purify a neural crest 
cell population. Already 6-8 days after EB plating, the crescent-shaped delaminates could be 
easily discerned and isolated with a canula or pipette tip. Manual isolation is a more efficient 
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method than FACS, as the same purity is achieved but additionally a higher quantity of cells 
is yielded. It is considerable faster and cheaper than FACSorting and less amenable to con-
tamination. The isolated homogeneous cell population expressed typical neural crest markers 
such as p75NTR and SOXE with a purity of >95% and proliferated in culture. However, after 
prolonged culture the proliferation rate decreases and for differentiation experiments popula-
tions maintained for no longer than three passages were used. It is likely that FGF2 and EGF 
are not sufficient to keep the cells proliferating. Furthermore it has been observed that neu-
ronal differentiation potential of the cells decreased over prolonged time in culture. This goes 
in line with published findings showing that over prolonged culture of neural crest cells the 
differentiation potential is shifted towards skeletogenic and osteogenic fates (Colleoni et al., 
2010). The presence of the growth factor FGF2 may be one cause of this, as FGF2 is known 
to favor the mesenchymal differentiation of cranial neural crest cells (Sarkar et al., 2001). In 
this thesis, the chondrogenic effect of FGF2 has been used in the chondrocyte differentiation 
paradigm. 
Further studies are required to find specific culture conditions that support proliferation and 
prolonged multipotency of the isolated hES cell-derived neural crest cells. It was shown by 
Sommer group that the combination of BMP and WNT keeps primary mouse neural crest 
cells in a proliferating state, while the sole application of BMP alone yields differentiation 
towards autonomic neurons and smooth muscle, whereas the sole application of WNT pro-
motes the differentiation towards sensory neurons (Kleber et al., 2005). The protocol in its 
published form could not be successfully transferred to hES cell-derived neural crest cells 
(data not shown). Culture conditions may need to be adjusted to human neural crest cells in 
terms of application of other proliferation-inducing cues or additional factor combinations. 
Another reason for the declining proliferation and differentiation capacity may be that proba-
bly the obtained neural crest population is rather a pool of fate-restricted progenitors than true 
multipotent neural crest stem cells. So the question comes up: Are neural crest cells specified 
at the time they are born or are they multipotent at first and then fate restricted by the envi-
ronment they migrate into? This subject has been addressed by many neural crest researchers 
and extensively discussed in the literature. However, some studies point at contradictory re-
sults and there also seem to be specie specific differences, so that up to date the issue is not 
clarified (for review see Ruhrberg and Schwarz, 2010 and Sandell and Trainor, 2006). 
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One argument for the hypothesis of pre-specification of neural crest cells are the results of the 
lineage tracing studies of Krispin and colleagues, which suggest that avian neural crest deriva-
tives follow a spatiotemporal fate map. The diversion of prospective neuronal precursors into 
the melanocytic pathway did not cause a change in their neuronal fate (Krispin et al., 2010). 
As neural crest migration routes change during development, with the first wave migrating 
medio-ventral and the second wave migrating dorso-lateral, another study examined whether 
early migrating neural crest cells will change their migration route when transplanted into 
older hosts and vice versa. Here it was found that neural crest cells did not change their mi-
gration route when transplanted into hosts at different stages of development, indicating that 
neural crest cells are pre-specified by the time of delamination and that their fate is not deter-
mined by environmental cues (Erickson and Goins, 1995). Another research result emphasiz-
ing the hypothesis of pre-specified neural crest cells is that prospective melanoblasts, which 
migrate as last wave from the neural tube, express melanogenic markers from their very 
emergence on (Thomas and Erickson, 2008).  
Contradictory to these findings, studies on zebrafish and mice aiming at the transplantation of 
neural crest cells to different positions showed that plasticity of migrating neural crest cells 
depends on the size of the graft as well as on the developmental stage. The cell fate of trans-
planted individual cells was determined by the new environment, while grafts consisting of 
small groups of cells kept the fate determined by their origin. Also, adaption to the new envi-
ronment was more efficient when transplantation was done during early development 
(Schilling et al., 2001; Trainor and Krumlauf, 2000)  These studies point out that in addition 
to the impact of environmental cues, also cellular interactions between neural crest cells con-
tribute to neural crest cell fate. Additionally, it was shown that apparently fate-restricted trunk 
neural crest cells, which during development do not give rise to cranial derivatives, could be 
differentiated towards mesenchymal derivatives by cultivating them in appropriate conditions 
or transplanting them in the cranial region (McGonnell and Graham, 2002; Real et al., 2005).  
 
Isolated neural crest cells show upregulation of typical neural crest markers when com-
pared to neural stem cells by microarray analysis 
The conducted microarray analysis shows a significant upregulation of various neural crest-
associated genes in the isolated neural crest aggregates in comparison to a stable proliferating 
neural stem cell line generated from the same parental hES cell line (lt-hESNSCs, Koch et al., 
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2009). Among these are NGFR (p75NTR) and SOX10, genes typically used to identify neural 
crest cells. The expression of those markers could also be observed in the isolated population 
by RT-PCR, immunocytochemistry, as well as Western blot analysis. Two of the most 
upregulated genes in the isolated neural crest aggregates are MSX1 and TFAP2A. Both genes 
have been shown to be important for cranial neural crest development (Ishii et al., 2005; 
Schorle et al., 1996). Mutations in these genes are also related with cleft lip or palate in hu-
mans (Milunsky et al., 2008; van den Boogaard et al., 2000). Dysregulation of SOX9, which is 
also strongly upregulated in the isolated neural crest cells, is also connected with orofacial 
disorders, such as Pierre Robin syndrome (Benko et al., 2009; Jakobsen et al., 2007). TWIST 
has been shown to be important for proper neural crest delamination and migration of mouse 
cranial neural crest cells (Vincentz et al., 2008).  S100 proteins are widely expressed through-
out many tissues and are also present in the neural crest and in its derivatives Schwann cells, 
melanocytes, chondrocytes and adipocytes. hES cell-derived neural crest cells show an 
upregulation of S100A10 and S100A11 (Kahn et al., 1984). TFAP2B, expressed in neural crest 
cells, has been shown to be involved in Char syndrome, which involves facial dysmorphism, 
patent ductus ateriosus and hand anomalies (Satoda et al., 2000).  
The important role of Cadherins in neural crest delamination and migration has been de-
scribed above. Microarray analysis showed an upregulation of CDH11 (Cadherin-11) in the 
isolated neural crest aggregate in comparison to neural stem cells. Cadherin-11 is also known 
as osteoblast cadherin and is involved in skeletal development (Di Benedetto et al., 2010). 
This relates to the presented potential of hES cell-derived neural crest cells to differentiate 
into osteoblasts. SNAI1 and SNAI2, both early neural crest determinants are also highly ex-
pressed in the isolated population. Members of the Snail family play an important role in neu-
ral crest specification. Furthermore, depletions of members of the Snail family led to severe 
craniofacial defects including cleft palate in mice (Murray et al., 2007). ERBB3 encodes for 
receptor tyrosine-proetine kinase erbB-3, a member of the EGF receptor family, which binds 
to NRG-1. The NRG-1/ERbB system fulfils several functions in neural crest development. 
For instance, it promotes the development of Schwann cells, and was therefore used in the 
presented Schwann cell differentiation paradigm (Syroid et al., 1996). EDNRA, encoding for 
the endothelin receptor type A, is also upregulated in the isolated population. It binds to endo-
thelin-1 (edn1) and supposedly is downstream of the early neural crest specifier MSX1, but 
upstream of SOX9 and SOX10 (Bonano et al., 2008). It has been shown to inhibit apoptosis 
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and is required for neural crest migration. Furthermore, mice depleted for Ednra/Edn1 die 
shortly after birth due to severe neural crest malformations, associated with cranial and car-
diac neural crest cells. POU4F1, also known as BRN3A, is a transcription factor that plays a 
central role in the development of sensory neurons (Abe et al., 2007). The expression of this 
transcription factor has also been detected in the sensory neurons derived in this thesis by 
immunocytochemical analysis, as well as by RT-PCR. Although many upregulated genes de-
tected in the microarray analysis point towards the mesenchymal differentiation potential, the 
upregulation of this gene demonstrates the neuronal differentiation potential of the hES cell-
derived neural crest cells. 
In addition to the upregulated neural crest associated genes in the isolated population, several 
genes linked to CNS development were found downregulated. These include FABP7, encod-
ing for a brain fatty acid protein involved in neurogenesis in CNS development, the transcrip-
tion factors SOX3, SOX2, as well as PAX6. SOX2 and PAX6 are, additionally to their expres-
sion in the developing CNS, also involved in the development of the lens and olfactory 
placode. POU3F2 (BRN2), as well as ASCL1 (MASH1), have recently been discovered as two 
of the three factors capable to directly convert murine fibroblasts into functional neurons in 
vitro. PROM1, also known as CD133, is a marker typical used to identify neural stem cells, 
which is also associated with several types of tumorigenic cells. MMRN1 has been described 
as marker expressed in neural tube-like structures. HES5, a target gene of the Notch pathway, 
is involved in the maintenance of neural stem cells, in which it is highly expressed. Neural 
stem cells overexpressing HES5 fail to differentiate (Ohtsuka et al., 2001). Another gene 
upregulated in the lt-hESNSCs compared to the isolated neural crest population is PLAGL1 
(ZAC1). PLAGL1 has been identified in the highly proliferating areas of the embryonic brain, 
as well as neural retina and neural tube. To sum up, the microarray analysis underlined the 
marker profile of the isolated hES cell-derived neural crest cells. Furthermore it can be ex-
cluded that the population harbors neural stem cells or are rather of placode identity. Placode 
cells also form cranial ganglia, but express a different marker profile. Additionally, they do 
not give rise to autonomic neurons, cartilage, or smooth muscle (Baker and Bronner-Fraser, 
2001). 
As other laboratories also published findings about pluripotent stem cell-derived neural crest 
cells, an interesting approach would be to compare the human neural crest cells derived in this 
work with other lines. Differences in differentiation potential and marker expression already 
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give a hint on different neural crest identities. The comparison could offer valuable cues re-
garding the characteristics of pluripotent stem cell-derived neural crest cells. 
 
Implications for the derivation of neural stem cell lines from neural tube-like structures 
The closely related development of neural crest cells and neural tube-like structures further-
more explains the often-observed contamination of neural stem cell populations with neural 
crest cells (Philipp Koch, personal communication). This contamination problem of neural 
rosette-derived neural stem cells might be avoided by application of agents inhibiting neural 
crest development. The BMP antagonist Noggin controls neural crest emergence in vivo by 
inhibiting BMP4, which is needed for neural crest delamination (Sela-Donenfeld and Kal-
cheim, 2000). Application of BMP antagonists, such as Noggin, in a neural crest differenti-
ation protocol has been shown to reduce the number of obtained neural crest cells (Lee et al., 
2007). Another candidate for neural crest abrogation is the anti-inflammatory drug lefluno-
mide, which inhibits dihydroorotate dehydrogenase and has been shown to completely pre-
vent neural crest development (White et al., 2011). Obviously, the inhibition of neural crest 
development does not only play a role in protocols aiming at the derivation of pure cultures of 
neural stem cells, it is also of high importance in the study of neural crest-derived tumours, 
such as melanoma and schwannoma. The here described cell culture model offers the possi-
bility to study effects of neural crest inhibitors in an in vitro setting.   
 
Manually isolated neural crest cells differentiate into peripheral neurons and glia 
Upon manual isolation and singularizing of neural crest aggregates, differentiation of neural 
crest cells into 21.7±5.1% Peripherin/BRN3A positive cells, a marker combination commonly 
used for sensory neurons, was feasible. The application of recombinant WNT1 was not re-
quired for differentiation of hES cell-derived neural crest cells into sensory neurons. How-
ever, it has been shown that neural crest cells that can be efficiently differentiated into sensory 
neurons in the presence of WNT (Lee et al., 2004). It has also been reported that neural crest 
cells lose their responsiveness to WNT when cultured for a prolonged period of time (Kléber 
et al., 2005). In our hands, addition of WNT yielded only a minor increase in the amount of 
Peripherin/BRN3A positive sensory neurons, but increased the survival of differentiated neu-
rons (data not shown). According to Zirlinger and colleagues, neural crest cells acquire a de-
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velopmental bias towards neuronal fate early in their development (Zirlinger et al., 2002), as 
also discussed above. In agreement with this finding stands the observation made in this work 
that neural crest cells cultivated for prolonged periods of time were less accessible to the neu-
ronal differentiation paradigm (data not shown). This has also been reported for hES cell-
derived neural crest cells from other groups and for neural stem cells (Colleoni et al., 2010; 
Elkabetz et al., 2008). 
The RT-PCR profile offered valuable cues to the identity of differentiated neurons. On the 
one hand, the sensory neuronal fate was confirmed, as cells showed expression of POU4F1 
(BRN3A), as well as SOX10, and PAX3, which also play a role in sensory neurogenesis 
(Carney et al., 2006; Koblar et al., 1999). The expression of PAX3 and SOX10 in sensory neu-
rogenesis and in undifferentiated neural crest cells is a good example for the complex gene 
regulatory network of neural crest cells. Many of the described genes are of recurrent impor-
tance during the life of neural crest cells. Some genes that play key roles in delamination or 
maintenance of neural crest stemness are again present in differentiated lineages.  
For the more detailed apportionment of the obtained neuronal population, the expression of 
NTRKs was investigated. While the detected NTRK1 (TrkA) marks small diameter neurons, 
NTRK2 (TrkB) and NTRK3 (TrkC) are expressed in large diameter neurons of the dorsal root 
ganglion (Mu et al., 1993). Consequently it can be recorded that the isolated neural crest cell 
population gives rise to different subtypes of sensory neurons. Further investigation of sen-
sory neurogenesis will greatly contribute to the understanding of diseases associated with the 
loss of sensory neurons and consequently for the development of therapeutic approaches.  
In addition to sensory neurons a small percentage of Peripherin/TH positive cells could be 
obtained, indicating peripheral neurons of the autonomic type. RT-PCR also showed expres-
sion of TH on molecular level. Surprisingly, TH could also be detected in proliferating neural 
crest cells. This observation is coherent with published data from Young and colleagues, 
showing that TH is already expressed in a subset of proliferating neural crest cells (Young et 
al., 1999).  The expression of ASCL1 and PHOX2B mRNA in differentiated cultures could be 
detected as well. Both genes are essential for the development of the peripheral autonomic 
nervous system, which main components are the sympathetic, parasympathetic and enteric 
ganglia (Guillemot et al., 1993; Pattyn et al., 1999). No HB9 expression was detected in the 
cultures, so that it can be excluded that the expression of those markers originates from CNS 
motorneurons derived from possibly contaminating neural stem cells. Importantly, those cells 
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were generated without external stimulation with BMPs. It has been shown that BMP en-
hances autonomic neurogenesis by causing an upregulation of the transcription factor ASCL1 
(Gossrau et al., 2007; Kleber et al., 2005; Mizuseki et al., 2003; Shah et al., 1996) suggesting 
that additional application of BMPs could be used to further increase the numbers of periph-
eral autonomic neurons in the differentiated culture.  
Additionally to the expression of specific antigens assessed by immunocytochemical analysis 
and the expression of neuronal-associated genes assessed by RT-PCR, the functionality of the 
differentiated neurons was shown by electrophysiological measurements. All neurons tested 
fired action potentials during current injection. Also, the peripheral neurons formed functional 
synapses, as spontaneous postsynaptic currents were observed in whole-cell voltage-clamp 
recordings.   
 
In addition to neurons of the peripheral nervous system, hES cell-derived neural crest cells 
give rise to putative Schwann cells, which express combinations of Schwann cell markers as 
assessed by immunocytochemical analysis and RT-PCR. Cells showed expression of 
L1CAM, GFAP, p75NTR, CNP, SOX10, and EGR2 (for review see Jessen and Mirsky, 
2005). SOX10 and p75NTR are expressed in proliferating neural crest cells as well as in 
Schwann cells derived thereof. The same is true for L1CAM. The neuronal cell adhesion 
molecule has been shown to be important for the migration of neural crest cells and is also 
retained in Schwann cells (Anderson et al., 2006b; Jessen and Mirsky, 2005).  
The surprisingly high expression of CNP already in proliferating cells is compatible with pub-
lished data showing the early activation of the CNP promoter in neural crest progenitors 
(Chandross et al., 1999). It will be interesting to further investigate whether the hES cell-
derived Schwann cells are able to form myelin. This could be either achieved in vitro by co-
cultivation with dorsal root ganglion cultures or by transplanting them into nerve-injured ani-
mal models.  
Schwann cells derived from pluripotent cells could gain intensive attention in terms of cell 
replacement therapies, especially with progressing iPS technology. Not only could they be 
used for remyelination in the injured or diseased PNS, they also provoke promises for CNS 
repair, in terms of trauma or demyelination disorders (Lavdas et al., 2008). Additionally they 
could be used as vehicles to secrete active agents facilitating spinal cord repair. In general, for 
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enrichment of peripheral glia one could think of an intermediate purification step of precursor 
cells. Prior to the terminal differentiation step, FACSorting for early Schwann cell markers, 
like e.g. L1CAM could be applied to enrich the cultures. Thereby it could be possible to gen-
erate Schwann cell cultures of high purities. 
 
Manually isolated neural crest cells have the potential to differentiate into cranial neural 
crest phenotypes 
In addition to neural phenotypes manually isolated neural crest cells could be successfully 
differentiated into smooth muscle, osteoblasts, chondrocytes and adipocytes. For smooth 
muscle differentiation it was sufficient to add 10% FCS to the culture medium. This has also 
been described in other hES cell-derived neural crest cells (Colleoni et al., 2010). As RT-PCR 
revealed expression of ACTG2 (γSMA), the hES cell-derived neural crest cells exhibit poten-
tial to differentiate into enteric smooth muscle. This is in line with the detected enteric neuron 
marker PHOX2B expression after neuronal differentiation. Enteric neural crest derivatives can 
either have a vagal or sacral origin (Anderson et al., 2006a), the identity of the cells differen-
tiated by this paradigm could not be determined. 
Distinct culture conditions promoted the formation of chondocytes, osteoblasts, and adipo-
cytes. For chondrogenesis, FGF2 as well as FGF8 have been identified as inducer (Ido and 
Ito, 2006; Trainor et al., 2002). In the presented cell culture paradigm, FGF2 in combination 
with Forskolin and the presence of FCS, led to the formation of cartilage-like clusters. For the 
osteogenic and adipogenic differentiation, published medium conditions were applied (Fang 
et al., 2005). For the differentiation of osteoblasts, Dexamethasone was used, a synthetic ster-
oid hormone of the glucocorticoid class. Medically prescribed as anti-inflammatory drug, it is 
known to have a positive effect on osteoblast proliferation and differentiation (Cheng et al., 
1994). Relatively little is known about the differentiation of adipocytes from the neural crest 
in comparison to other neural crest-derived mesenchymal cells, although Le Lievre and Le 
Douarin already suggested in their pioneer work of 1975 that some facial adipocytes are neu-
ral crest derived. Back then it was discovered that the adipocytes around the trachea and para-
sympathetic enteric ganglia, as well as the adipocytes in the skin under the skullcap and in the 
ventral part of the neck are of neural crest origin (Le Lievre and Le Douarin, 1975). Recent 
work has shown that mouse ES cell-derived neural crest cells give rise to adipocytes in vitro. 
In the same publication it was suggested that the adipocytes in the ear region and salivary 
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gland are also neural crest derived (Billon et al., 2007). In this thesis for the in vitro differen-
tiation of human neural crest cells, hydrocortisone, another steroid hormone of the same class 
as Dexamethasone but naturally occurring and produced by the adrenal gland, was applied for 
adipocyte differentiation. Hydrocortisone causes adipocytes to store fat, explaining why adi-
posity is a common side effect of long-term medication with hydrocortisone. Hydrocortisone 
is widely used in differentiation paradigms of mesenchymal cells (Eshel et al., 1990). Isobu-
tylmethylxanthine is another adipogenic agent, which was used in the presented differentia-
tion paradigm. Isobutylmethylxanthine increases the intracellular level of cAMP and addi-
tionally acts on the upregulation of adipocyte transcripition factors (Elks and Manganiello, 
1985). Staining of intracellular lipid droplets with oil red could demonstratively identify the 
fat cells differentiated by this treatment from the isolated hES cell-derived neural crest popu-
lation. The observation that the hES cell-derived neural crest cells give rise to chondrocytes, 
osteoblasts and adipocytes indicate that the derived cell population displays a cranial identity. 
This hypothesis is supported by the expression of HOXA2 and –B2, OTX2 and GBX2. In vivo, 
HOXA2 and –B2 mark neural crest cells migrating in the second brachial arch (Hunt et al., 
1991). Additionally expression of GBX2 and OTX2, both expressed in cranial migrating neu-
ral crest cells (Kikuta et al., 2003; Kimura et al., 1997) was detected. The expression profile, 
as well as the mesenchymal derivatives, suggests that cells exhibit a cranial identity. How-
ever, as neural crest cells from different regions have been shown to exhibit plasticity (Trainor 
and Krumlauf, 2000), it cannot be excluded that the applied culture conditions caused com-
mitted neural crest cells to regain multipotency, as it has been shown for trunk neural crest 
cells in the mouse (McGonnell and Graham, 2002). Therefore the possibility exists that the 
isolated cell population is a mixed pool of neural crest cells of different regional identities 
instead of a neural crest cell population with true stem cell characteristic. 
While hES cell-derived neural crest cells could be successfully differentiated into peripheral 
neurons and glia as well as to mesenchymal derivatives, differentiation towards melanocytes 
could not be achieved in this thesis. Future studies will show whether improved culture condi-
tions will lead to melanocyte differentiation or whether the melanocyte lineage arises from 
another already restricted neural crest ancestor cell, which is not accessible at this time point 
and using this type of isolation. Although some published protocols show the differentiation 
of pigment cells from hES cell-derived neural crest cells, it remains to be clarified whether the 
obtained cells are truly melanocytes or retina pigmented epithelial cells derived from placode 
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cells. Even though both cell types display a pigmented phenotype, they differ in their mor-
phology. Retina pigmented epithelial cells exhibit a small roundish cell shape, while melano-
cytes have widely branched dendrites.  
Although it could be shown that isolated neural crest cells give rise to several neural crest 
phenotypes, analysis of isolated cells at a clonal density will help understanding whether these 
cells exhibit true fate plasticity. It will be interesting to investigate whether the isolated cell 
population is a pool of already committed neural crest precursor cells or a neural crest stem 
cell population, for which the ideal propagating culture conditions have not been found yet.  
 
4.3 Outlook  
Due to the fact that the in vivo situation of neural crest cells development can be mimicked 
and followed in vitro, the hES cell-based cell culture model presented here provides important 
insights regarding emergence, migration, re-aggregation and differentiation of human neural 
crest cells. It can serve as a useful tool for the investigation of signaling pathways involved in 
human neural crest development. Another interesting approach is transplantation of isolated 
hES cell-derived neural crest cells into embryonic chicken in order to investigate their migra-
tion pathways and differentiation behavior. As described above, several protocols show dif-
ferent approaches for the derivation of neural crest cells from hES and iPS cells (for review 
see Chimge and Bayarsaihan, 2009 and Achilleos and Trainor, 2012). It will be interesting to 
compare those alternatively derived neural crest cells, e.g. by microarray analysis and to in-
vestigate whether differences exist regarding their transcriptional profile. Possibly they ex-
hibit a different regional identity and therefore also display a distinctive differentiation poten-
tial.  
The knowledge that can be gained by using this hES cell-based model may lead to a better 
understanding of diseases related with neural crest abnormalities, including neural crest re-
lated cancers like neuroblastomas and schwannomas, but also of diseases associated with neu-
ral crest malformations. As the hES cell-derived neural crest cells presented in this thesis ex-
press several markers of cranial neural crest cells, diseases especially caused by abnormal 
development of those cells will be interesting targets, such as cleft lip and palate, Bardet-
Biedl syndrome, CHARGE syndrome or DiGeorge syndrome. The fast growing field of iPS 
cell technology offers a broad range of new possibilities regarding this matter in this area. A 
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recent study shows the use of patient-specific cell lines as disease model for familial 
dysautonomia (Lee et al. 2009). Due to its quoted advantages the model system described 
here could also be adapted and efficiently used in iPS cell research for disease modeling of 
neurocristopathies.  
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7 Appendix 
Time-lapse microscopy: supplementary movies 
 
Movie 01: Time-lapse microscopy of plated EB  
5-day-old EB was plated on a fibronectin-coated cell culture dish. Cell migration was moni-
tored 72 hours. Scale bar: 100 µm. 
 
Movie 02: Time-lapse microscopy of re-plated crescent-shaped aggregate 
Crescent-shaped aggregate containing neural crest cells was isolated from an 8-day-old EB 
outgrowth and re-plated on a fibronectin-coated cell culture dish. Cell migration was moni-
tored for 72 hours. Scale bar: 100 µm. 
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